Haploid inducing composition and method of use thereof
By applying phospholipase inhibitors or modifying the PLA2 gene during maize pollination, the problems of low haploid induction rate and high embryo abortion rate in maize were solved, achieving efficient haploid induction and improved seed setting rate.
Patent Information
- Application Number
- CN202210875127.2
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Priority Date
- 2016-02-26
- Filing Date
- 2016-11-17
- Publication Date
- 2024-11-12
- Estimated Expiration
- 2036-11-17
AI Technical Summary
In existing technologies, the haploid induction rate is low, the embryo abortion rate and fertilization failure rate are high during the haploid induction process of maize, resulting in low seed setting rate and limiting the yield of double haploid inbred varieties.
Haploid embryos can be induced by applying specific chemicals, such as phospholipase inhibitors methyl α-linolenic acid fluorophosphonate (MALFP) and ethyl linoleate (LLAEE), to maize flowers during pollination, or by altering the expression or sequence of the PLA2 gene in maize plants, and by using technologies such as CRISPR/Cas9 to modify maize plants.
It significantly improved the haploid induction rate, reduced the embryo abortion rate and fertilization failure rate, increased the number and seed setting rate of haploid grains, and improved the yield of double haploid plants.
Smart Images

Figure CN115918526B_ABST
Abstract
Description
[0001] This application is a divisional application of the invention patent application with the application date of November 17, 2016, application number 201680067447.8, and invention name "Haploid inducing composition and method of use thereof".
[0002] Claiming priority
[0003] This application claims the benefit under 35 U.S.C. §120 of U.S. Provisional Application No. 62 / 256,902, filed on November 18, 2015, and U.S. Provisional Application No. 62 / 300,507, filed on February 26, 2016, the contents of which are incorporated herein by reference.
[0004] Sequence Listing
[0005] This application is accompanied by a sequence listing, which is designated as 80906-PCT_ST25.txt, created on November 16, 2016, and is approximately 392 kilobytes in size. This sequence listing is incorporated herein by reference in its entirety. This sequence listing is submitted with this application via EFS-Web and complies with 37 C.FR §1.824(a)(2)-(6) and (b). Technical Field
[0006] The subject matter disclosed in the present application relates to the identification detection of haploid induction ("HI") or its absence and / or presence in plants that are or are not haploid inducers. More specifically, the subject matter disclosed in the present application relates to nucleic acids that can be used to induce HI in plants and / or induce biological activities that can be modified to produce or prevent HI in plants that would otherwise exhibit HI or in plants that would not otherwise exhibit HI. Even more specifically, the subject matter disclosed in the present application relates to nucleic acid molecules encoding biologically active molecules and methods of using the nucleic acid molecules to modulate HI in plants.
[0007] Provided herein are a series of independent human-induced mutations found in at least one potato glycoprotein-like phospholipase A2α ("PLA") gene of corn; corn plants having these mutations in at least one PLA gene; and methods for generating and identifying similar and / or additional mutations in PLA genes by screening pooled and / or individual corn plants. The corn plants of the present invention have induced haploidy due to non-transgenic mutations in at least one PLA gene. Also provided are methods for inducing de novo haploid induction by applying chemicals to reproductive tissues of plants. Also provided are methods for increasing seed set and haploid induction rate ("HIR", defined herein as the number of haploid kernels surviving after pollination of the ear with haploid inducer pollen divided by the total number of kernels) by applying chemicals to reproductive tissues of plants during pollination. Background Art
[0008] Pollination is a complicated process. Angiosperm pollen grains are composed of a large vegetative cell and two male gametes (sperm cells). After falling on the stigma, pollen grains germinate pollen tubes, and as the pollen tubes sail downward along the pistil conducting tube (femaletransmitting tract), guided by the chemical attractants secreted by two synergids at the micropylar end of the embryo sac, the pollen tubes show rapid tip growth. In the process of passing down along the tube, sperms are connected to each other and to the vegetative nucleus by the sticky cytoplasm that is called the male reproductive unit. Soon after contacting one of the two synergids, the pollen tubes break and two sperms are pushed through the cytoplasm of the synergids that are about to disappear to fuse with the egg and the central cell of the embryo sac independently, thereby completing double fertilization. Even after the initial contact, the fertilization failure event can also be saved by the second pollen tube, which fertilizes the embryo sac via interacting with the persistent synergids.
[0009] In order to form hybrid seeds, breeders hybridize inbred parent lines, one serving as male parent and one serving as female parent. The process of developing substantially isozygous inbred parent lines usually requires to be selected and self-pollination (selfing) for many generations to become close to isozygous hybrids. This process is time-consuming and expensive. In order to shorten the time of developing isozygous inbreds in corn, rice, wheat, barley and other crops, breeders can choose to use haploid inducer lines to induce the haploid seeds of hybrid parents to produce. Then the chromosome of haploid plant is doubled, for example, by chromosome doubling agent such as colchicine, to form double haploid isozygous inbred lines.
[0010] Haploid induction ("HI") is a class of plant phenomena characterized by the loss of inducer chromosomes during embryo development. WO 2012 / 030893 (incorporated herein by reference) describes a region of maize chromosome 1 that may be responsible for haploid induction. The markers identified in this region that improve haploid induction are described as being between 48,249,509-51,199,249, which are associated with a public marker umc1169 with a physical position of (60,213,661). This region does not appear to align with the haploid induction region in Stock 6. Dong et al., (2013) Theor.Appl.Genet. [Theory and Application of Genetics] 126: 1713-1720 describe a QTL located in bin 1.04 that explains up to 66% of the genotype variance of HIR.
[0011] Haploid induction has been observed in many plant species (such as sorghum, barley, wheat and other grasses). In corn, HI appears to be the result of rearrangements, mutations and / or recombination, insertions or deletions within the chromosome 1 region (with the notable exception of ig-type haploid induction, which is the result of mutations in the INDETERMINATE GAMETOPHYTE1 gene on chromosome 3). The legendary HI lines have been studied and roughly identified. However, experimental evidence proving the inducing genetic factors of HI in corn has not yet been proposed. The markers associated with this trait listed in this article have not been identified before.
[0012] In corn, haploid seeds or embryos are specifically produced by hybridizing between the haploid inducer male parent (i.e. "haploid inducer pollen") and any ear that people actually select - the ear can be any inbred species, hybrid or other germplasm. Haploid is produced when the haploid inducer pollen DNA is not fully transmitted and / or maintained by the first cell division of the embryo. The phenotype produced is not fully penetrant, in which some ovules contain haploid embryos, and other contain diploid embryos, aneuploid embryos, mosaic embryos or aborted embryos. Haploid grains have embryos containing only maternal DNA plus normal triploid endosperm. After haploid induction, phenotypic or genetic marker screening is used to typically separate haploid embryos or seeds from diploid and aneuploid siblings, and grow or cultivate them into haploid plants. These plants are then naturally or via chemical manipulations (i.e., colchicine) converted into double haploid (DH) plants, which then produce inbred seeds.
[0013] HI lines contain a quantitative trait locus ("QTL") on chromosome 1 that is responsible for at least 66% of the variation in haploid induction. When it is introgressed into different backgrounds, the QTL causes haploid induction at different rates. All haploid inducer lines used in the seed industry are derivatives of an established HI line, called Stock6, and all have mutations in the haploid inducer chromosome 1 QTL. Here, we reveal a key mutation in this QTL that rescues normal reproduction upon compensation. Although the origin of this mutation is unclear, it is present in all inducer lines, including Stock6.
[0014] Plant breeding is assisted by using double haploid (DH) plants. The generation of DH plants enables plant breeders to obtain inbred lines without the need for multi-generation inbreeding, thereby reducing the time required to produce homozygous plants. DH plants provide valuable tools for plant breeders, particularly for the generation of inbred lines, QTL positioning, cytoplasmic conversion, trait introgression and for the F2 screening of high-throughput trait improvement. Since homozygous lines are basically produced in one generation, a large amount of time is saved, negating the need for multi-generation traditional inbreeding. Specifically, because DH plants are completely homozygous, they are very suitable for quantitative genetics research. The generation of haploid seeds is crucial for the double haploid breeding process. When fertilized with pollen from gynogenetic inducer (such as Stock 6), haploid seeds are produced on maternal germplasm.
[0015] Maize haploid inducer plants produce pollen that, when crossed with non-induced germplasm, results in the gynogenic development of haploid seeds. Unfortunately, this process often produces a low frequency of haploid kernels. The inefficient haploid induction frequency is a limiting factor in maize doubled haploid breeding programs. Summary of the invention
[0016] High HIR allows for a higher frequency of haploid seeds to be formed on the parental plants of interest. Parental plants can be pre-screened with genetic markers associated with desired traits or phenotypically observed traits to enrich the genetic potential of parental plants. When these desired parental plants are pollinated with haploid inducers having a higher HIR, the potential for obtaining desired doubled haploids having the desired genotype and phenotype is higher.
[0017] Although the double haploid process leads to faster production of homozygous inbreds, the amount of double haploid inbreds produced may be limited. Known inducer strains include, but are not limited to: Stock 6, MHI (Moldovian haploid inducer), indefinite gametophyte ("ig") mutation, KEMS, RWK, ZEM, ZMS and KMS. All have relatively low HIR. For example, Stock 6 only induces 1%-3% of haploid seeds. Therefore, in the process of producing double haploid strains, the induction of haploids has always been the rate-limiting step.
[0018] We have invented ways to induce haploid production and / or increase the rate of haploid induction in plants by treating plants with lipid compounds, phospholipase inhibitors, and fatty acid desaturase inhibitors. One set of such methods involves applying specific chemicals to reproductive tissues when crossed with wild-type (non-haploid inducer) pollen. For the first time, we triggered de novo haploid induction chemically. This was achieved by applying a concentration of the phospholipase inhibitor methyl alpha-linolenoyl fluorophosphonate (MALFP) to flowers during pollination, which resulted in high rates of haploid induction: up to 9% HIR. Separately, we triggered de novo haploid induction by applying a concentration of arachidonyl fluorophosphonate (MAFP) to flowers during pollination. Separately, we triggered de novo haploid induction by applying a concentration of 1,2-distearoyl-sn-glycero-3-phosphatidylcholine (also known as distearoyl-phosphatidylcholine; "DSPC") to flowers during pollination. We also triggered de novo haploid induction by applying a certain concentration of α-linolenic acid to flowers during pollination. We also triggered de novo haploid induction by applying readily available compounds (including corn oil and linseed oil) as well as chemically synthesized linoleic acid, ethyl oleate (OAEE), methyl arachidonic acid (AAME) and the phospholipase inhibitor manoalide. By applying a certain concentration of the phospholipase inhibitor methyl α-linolenoyl fluorophosphonate (MALFP), we also increased the haploid induction rate when the plants were crossed with haploid inducer lines (e.g., RWK, Stock 6 or ZMS). At a concentration of 2% MALFP+surfactant blend 91 emulsified with a buffered DML solution, we doubled the haploid induction rate in pollination using RWK as a pollinator. The typical induction rate in RWK is about 10%-18%. With the application of MALFP, the induction rate increased to 20%-35%. We also increased the haploid induction rate by applying concentrations of linoleic acid (LLE), linoleic acid ethyl ester (LLAEE) and a phospholipase inhibitor called methylarachidonyl fluorophosphonate (MAFP) to flowers during pollination. In addition, doing so also reduced the embryo abortion rate and increased the grain formation rate of MALFP, LLAEE, MAFP and LLE. Together, these effects led to an increase in the total number of haploid embryos recovered on the ear after pollination.
[0019] We have also cloned and characterized the gene responsible for haploid induction in corn. The gene is PLA2 and it has pollen-specific expression. The PLA2 protein appears to be localized in the cytoplasm of sperm cells, perhaps the endoplasmic reticulum or the Golgi apparatus. The identification of the gene has led to the invention of several new technologies that improve the haploid induction process, defined as the act of producing haploid embryos, grains, seeds, or plants by hybridizing any ear with haploid inducer pollen. The identification of the gene has also led to the invention of new methods for inducing haploids. Another set of methods includes methods for producing new haploid inducer lines by changing the sequence of the inducing gene (by directed mutagenesis, TILLING, or CRISPR / Cas9). The expression of the PLA2 protein can be down-regulated using RNAi or by using targeted mutagenesis at the promoter, 3'UTR, 5'UTR, or splice site.
[0020] Based on the identification of this mutation, we have invented ways to improve and refine the haploid induction process, and for the first time, we disclose methods for de novo generation of haploids via chemical treatments during pollination. We demonstrate methods for increasing the haploid induction rate ("HIR", the percentage of haploid embryos found on a given haploid-induced ear), and methods for increasing kernel survival during haploid induction. We also discuss methods for generating new haploid inducer lines using genetic modification ("GM") or directed mutagenesis strategies.
[0021] The haploid induction process can be improved in a number of ways. First, one can work on improving the average HIR. Because the HIR is relatively low, the HIR is rate limiting in large-scale doubled haploid ("DH") plant production. See Figure 1. With a few exceptions, HIR is usually less than 25%, most commonly in the 10%-20% range, meaning that 75%-90% of the kernels are diploid. In some low-frequency cases, aneuploid embryos are also produced during haploid induction. Examples of compounds that have been shown to increase the number of haploids formed during haploid inducer crosses and / or the rate of haploid formation without increasing embryo abortion rates include methyl α-linolenoyl fluorophosphonate (MALFP), methyl arachidonyl fluorophosphonate (MAFP), linoleic acid (LLA), and linoleic acid ethyl ester (LLAEE). Secondly, one can reduce kernel abortion rates and fertilization failure rates during haploid induction, resulting in more kernels formed per ear. Kernel abortion occurs after successful fertilization occurs, but when a functional embryo or endosperm fails to develop, and as a result small, colorless kernels grow, lacking a mature embryo inside. Kernel abortion rates are high during haploid induction - between 10%-50% of fertilized ovules on the ear. This limits the number of haploid grains that one can recover on each ear. Fertilization failure results when the ovules cannot be fertilized by the pollen grains, and fertilization failure is characterized by the absence of any grain development after pollination. During haploid induction, this rate is often high - between 10%-70% of the grains on some haploid-induced ears cannot be fertilized, depending on the alignment of the maturity of the male and female flowers, the type of cross being made, and the genetics of the male and female plants. Examples of compounds that have been shown to increase the rate of viable grain formation by reducing fertilization failure and embryo abortion include the same four described above: MALFP, MAFP, LLA, and LLAEE. These four molecules, when applied to pollen, male flower ears, or other flower parts during haploid induction crosses, increase the number of haploids formed by increasing haploid induction rates and grain counts.
[0022] Finally, by making it possible to occur de novo haploid induction on the ear or in the ovule when selfing or hybridizing with pollen from a non-haploid inducer line, people can improve the haploid inducer process by negating the need for the haploid inducer father. These de novo haploid induction methods (including the use of phospholipids (such as DSPC), fatty acids (such as linolenic acid (LNA)), triglyceride common mixtures (such as corn oil and linseed oil) or phospholipase inhibitors (such as MALFP)) can be applied to any outcrossing or self-pollination to induce haploid in corn. Here, we have described examples falling into one or more of these categories, which constitute improvements or new inventions in the haploid induction process.
[0023] The present invention relates to a method for inducing haploid embryos in a cross between two parental plants. This is accomplished by altering the expression of a phospholipase in one of the parental plants. This alteration can be accomplished in several ways: by causing one of the parental plants to express a mutated phospholipase; or by applying a small interfering RNA to one or both of the parental plants, which results in inhibition of the phospholipase; or by transforming one of the parental plants with a mutated phospholipase; or by editing the phospholipase of one of the parental plants, for example by site-directed mutagenesis such as CRISPR or TALEN-based techniques. When the expression of a phospholipase in one of the parental plants is altered by one of these techniques, then when the parental plant is used for crosses, at least one haploid embryo is produced.
[0024] In one embodiment of the method, the phospholipase is a potato glycoprotein-like phospholipase. In another embodiment, the potato glycoprotein-like phospholipase is an ortholog of pPLAIIα, which is encoded by a nucleotide sequence comprising SEQ ID NO:1 or a sequence having at least 70% identity to SEQ ID NO:1. The nucleotide sequence encoding the potato glycoprotein-like phospholipase can be mutated, and in one embodiment, the nucleotide sequence has a frameshift mutation that produces an artificial stop codon. The frameshift mutation sequence comprises SEQ ID NO:3 or a sequence having at least 70% identity to SEQ ID NO:3.
[0025] Other mutations are possible and within the scope of the present invention. Site-directed mutagenesis can be used to generate more phospholipase mutations. According to embodiments of the present invention, CRISPR / Cas9, TALEN, zinc fingers and meganucleases are methods for achieving site-directed mutagenesis.
[0026] The present invention can be used for many types of hybridization between plant.In one embodiment, the parental plant used in hybridization is monocotyledon, for example corn, rice, barley and wheat.The parental plant can be the same monocotyledon species, or they can be different species.In another embodiment, the parental plant used in hybridization is dicotyledon, for example soybean, sunflower, tomato, pepper, beet or Brussels sprouts.In a preferred embodiment, the parental plant is corn or rice plant.In the scope of the present invention are haploid embryos produced by the method, haploid seeds comprising haploid embryos and haploid plants grown by haploid seeds.Equally within the scope of the present invention are double haploids produced by exposing haploid embryos to chromosome doubling agents such as colchicine or trifluralin.
[0027] The present invention relates to a cDNA comprising SEQ ID NO:3, or a sequence orthologous to SEQ ID NO:3, or a sequence having 70% identity to SEQ ID NO:3. In a preferred embodiment, the sequence orthologous to SEQ ID NO:3 encompasses potato glycoprotein-like phospholipases from corn, rice, wheat, soybean and sunflower. Specifically, the sequence orthologous to SEQ ID NO:3 includes the rice gene Os03g27610. In a more preferred embodiment, the sequence orthologous to SEQ ID NO:3 encompasses SEQ ID NO:23 and 73-81.
[0028] The present invention relates to plants containing a human-induced non-transgenic mutation in their potato glycoprotein-like phospholipase gene. In a preferred embodiment, the potato glycoprotein-like phospholipase gene is pPLAIIα. In another embodiment, the mutation causes a premature stop codon to be encoded in the gene. In a more preferred embodiment, the plant is any monocot or any dicot, but is particularly preferably corn or rice.
[0029] The present invention also relates to methods for inducing haploid embryos and seeds to be produced by treating plant reproductive tissues with compounds comprising lipids or phospholipase inhibitors. In one embodiment, treatment occurs before, during or immediately after pollination. The treated plant can be any monocot or dicot, but in a preferred embodiment, the plant is corn, rice, wheat, soybean, sunflower and beet. In another embodiment, the lipid or phospholipase inhibitor is selected from the group found in Table 7. In a preferred embodiment, the treatment compound comprises methyl alpha-linolenoyl fluorophosphonate ("MALFP"), linoleic acid ethyl ester ("LLAEE"), linoleic acid ("LLA"), corn oil, distearoyl-phosphatidylcholine ("DSPC") or methyl arachidonyl fluorophosphonate ("MAFP").
[0030] In another embodiment, the lipid or phospholipase inhibitor matches the following formula (I): In the present invention, W of formula (I) is carbon ("C"), phosphorus ("P") or sulfur ("S"); m can be 0 or 1; n can be 0 or 1; X is selected from the group consisting of OH, CN, O(C 1 -C 4 alkyl), halogen, C 1 -C 4 Alkyl, and C substituted by one, two or three halogen or carbonyl groups 1 -C 4 Alkyl; R 1 Selected from the group consisting of: H, C 1 -C 6Alkyl and C substituted with one or more hydroxyl groups 1 -C 6 Alkyl, wherein optionally one or more of the hydroxyl groups are esterified by a group independently selected from the group consisting of: or when W is S, R1 is a bond to W; each L is independently C 2 -C 30 A carbon chain optionally comprising one or more groups independently selected from alkenyl, alkynyl, phenyl and heteroaryl, and optionally interrupted by 1-6 oxygen atoms. When W is C and m is 1, then n is 0; however, when W is C and m is 0, then n is 1.
[0031] In a preferred embodiment, X is F, Cl, CF 3 , CCl 3 CF 2 H、CCl 2 H.CF 2 CF 3 , CCl 2 CCl 3 CF 2 Cl, CF 2 CH 3 、C(O)CH 3 In a more preferred embodiment, the halogen is F or Cl.
[0032] It is important to note that in R 1 In, C 1 -C 6 Alkyl groups include straight chain, branched chain and cyclic alkyl groups. 1 is C substituted with 1 to 6 hydroxyl groups 1 -C 6 alkyl.
[0033] In one embodiment, each L in formula (I) is independently C 2 -C 30 Carbon chain, including branched chain, which may be saturated, unsaturated or polyunsaturated. In a preferred embodiment, the carbon chain of L comprises 1 to 4 groups independently selected from alkenyl, alkynyl, phenyl and heteroaryl. Unsaturation is in the form of double bonds or triple bonds. Alkenyl or alkynyl may be within the carbon chain, or at the end relative to the carbon chain. Phenyl and / or heteroaryl rings may be connected in the carbon chain at the ortho, meta or para position, or may be at the end of the carbon chain. The aryl ring may be optionally substituted. In a preferred embodiment, the carbon chain is interrupted by 1 to 6 oxygen atoms. As used herein, "interrupted by..." means that the carbon chain comprises at least two carbon atoms in sequence, followed by an oxygen atom. For example, -CH 2 -CH 2-O-CH 2 -CH 2 -CH 3 It is a carbon chain interrupted by oxygen atoms. In a preferred embodiment, the carbon chain is interrupted by 1 to 2 oxygen atoms.
[0034] Examples of suitable carbon chains meeting the requirements of L include: (CH 2 ) 8 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -CH 3 ; (CH 2 ) 3 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -(CH 2 ) 4 -CH 3 ; (CH 2 ) 7 -(CH) 2 -(CH 2 ) 7 -CH 3 ;(CH 2 ) 8 -(CH) 2 -CH 2 -phenyl-CH 2 -(CH) 2 -CH 2 -CH 3 ; (CH 2 ) 8 -(CH) 2 -(CH 2 ) 2 -O-CH 2 -(CH) 2 -CH 2 -CH 3 ; and (CH 2 ) 8 -(CH) 2 -CH 2 -phenyl-O-(CH 2 ) 3 -CH 3 .
[0035] Treatment with these compounds is achieved by applying the compound by any of the following techniques: dipping, injection, spray-based topical application, nebulizer, pipette-based topical application, and brush-based topical application, and any other topical application. Preferred embodiments use a spray or nebulizer.
[0036] The present invention further relates to a method for increasing seed set and reducing embryo abortion in plants during haploid induction, the method comprising treating plant reproductive tissues such as filaments, tassels, pollen, spikes, kernels or other flowering tissues with a suitable concentration of a compound before, during or after pollination. In one embodiment, the compound is selected from the group consisting of members of Table 7. In another embodiment, the compound is methyl alpha-linolenoyl fluorophosphonate (MALFP). In another embodiment, the compound is linoleic acid (LLA), linoleic acid ethyl ester (LLAEE), linolenic acid (LNA), distearoyl-phosphatidylcholine (DSPC) or methyl arachidonyl fluorophosphonate (MAFP).
[0037] The present invention further relates to a method for improving the haploid induction rate in plants, the method comprising applying a lipid composition to plant tissue immediately before, during or after pollination. In one embodiment, the plant is a monocot or a dicot; or the plant is a corn plant or a rice plant. In another embodiment, the lipid serves as a phospholipase inhibitor and / or a fatty acid desaturase inhibitor. In another embodiment, the lipid is a fatty acid (e.g., LLA) or a fatty acid ester (e.g., LLAEE) with a specific chain length and saturation (eighteen carbons and two double bonds), which is a class of fatty acid chain lengths lacking in haploid inducer pollen. By way of illustration and not limitation, the lipid is, for example, the phospholipase inhibitor methyl alpha-linolenoyl fluorophosphonate (MALFP), dissolved in a buffered DMSO solution (MALFP concentration between 0.0001 mg / mL and 1 g / mL), or dissolved in a surfactant formulation and then emulsified in a buffered dimethylacetamide (DML) solution (MALF concentration between 0.0001 mg / mL and 1 g / mL). By way of further illustration and not limitation, the lipid composition is applied to the reproductive tissue of the plant by dipping, injection, spraying, misting, atomization, infusion, brushing or any other application method. In one embodiment, the lipid composition is combined with pollen in a mixture, and the mixture is then applied to the plant tissue. In another embodiment, the mixture is applied to the reproductive tissue of the plant, such as pollen or silk of a corn plant.
[0038] The present invention relates to a method for inducing de novo haploid induction in a plant, the method comprising applying a lipid compound to at least one reproductive tissue of a plant during, before or after pollination. In one embodiment, the plant is selected from the group consisting of monocots and dicots. In another embodiment, the plant is selected from the group consisting of rice, corn, wheat, sorghum, tomato, sugar beet, millet, barley, soybean, sunflower, cotton, oats, tobacco, vegetables, fruits and any other crop plants.
[0039] According to one exemplary embodiment, the invention includes corn or rice plants capable of induced haploidy due to a human-induced mutation in a potato glycoprotein-like phospholipase AIIα ("PLA") gene, and seeds, pollen, plant parts, and progeny of said plants.
[0040] According to yet another exemplary embodiment, the present invention includes a corn or rice plant capable of inducing haploidy produced by the following steps: obtaining plant material from a parent corn or rice plant, inducing at least one mutation in at least one copy of a PLA gene in the plant material by treating the plant material with a mutagen to produce a mutagenized plant material, culturing the mutagenized plant material to produce offspring rice or corn plants, analyzing the offspring rice or corn plants to detect at least one mutation in at least one copy of the PLA gene, selecting offspring rice or corn plants having the ability to induce haploidy compared to the parent rice or corn plant; and repeating the cycle of culturing the offspring rice or corn plants to produce additional offspring plants having the ability to induce haploidy.
[0041] Brief description of the sequences in the sequence listing
[0042] SEQ ID NO: 1 is the cDNA sequence of the non-mutated phospholipase found in GRMZM2G471240-NIL. The non-mutated phospholipase allele is renamed herein as MATRILINEAL.
[0043] SEQ ID NO:2 is the amino acid sequence encoded by SEQ ID NO:1.
[0044] SEQ ID NO: 3 is the cDNA nucleotide sequence of the mutant phospholipase found in GRMZM2G471240-mtl, comprising a 4 base pair insertion. The mutant phospholipase allele is renamed herein as matrilineal.
[0045] SEQ ID NO:4 is the amino acid sequence encoded by SEQ ID NO:3.
[0046] SEQ ID NO:5 is the GRMZM2G471240_nil.F1 primer.
[0047] SEQ ID NO:6 is GRMZM2G471240_nil.R1 primer.
[0048] SEQ ID NO:7 is GRMZM2G471240_rwk.F1 primer.
[0049] SEQ ID NO: 8 is the GRMZM2G471240_rwk.R1 primer.
[0050] SEQ ID NO:9 is the nucleotide sequence of the TALEN-induced MTL mutation in event 39A ID T1 individual 22808-3954 allele 1.
[0051] SEQ ID NO: 10 is the nucleotide sequence of the TALEN-induced MTL mutation in Event 23A T1 Individual ID 22808-3924 Allele 1.
[0052] SEQ ID NO: 11 is the nucleotide sequence of the TALEN-induced MTL mutations in event 81A T1 individual ID 22808-3932, event 81A individual ID 22808-3317, and event 81A individual ID 22808-3303.
[0053] SEQ ID NO: 12 is the nucleotide sequence of the TALEN-induced MTL mutation in event 39A ID 22808-3954 allele 2.
[0054] SEQ ID NO: 13 is the nucleotide sequence of the TALEN-induced MTL mutation in event 23A ID 22808-3924 allele 2.
[0055] SEQ ID NO: 14 is the nucleotide sequence of the TALEN-induced MTL mutation in Event 38A T1 Individual ID 22808-4108 Allele 1.
[0056] SEQ ID NO: 15 is the nucleotide sequence of the CRISPR-induced MTL mutation in Event 18A T1 Individual ID 22807-4016.
[0057] SEQ ID NO: 16 is the nucleotide sequence of the CRISPR-induced MTL mutation in Event 27A T1 Individual ID 22807-4073 Allele 1.
[0058] SEQ ID NO: 17 is the nucleotide sequence of the CRISPR-induced MTL mutation in Event 27A T1 Individual ID 22807-4081 Allele 1.
[0059] SEQ ID NO: 18 is the nucleotide sequence of the CRISPR-induced MTL mutation in Event 76A T1 Individual ID 22873-3999.
[0060] SEQ ID NO: 19 is the nucleotide sequence of the CRISPR-induced MTL mutation in Event 32A T1 Individual ID 22873-3991.
[0061] SEQ ID NO:20 is the nucleotide sequence of CRISPR guide RNA.
[0062] SEQ ID NO: 21 is the genomic nucleotide sequence of Os03g27610 (rice PLA2 ortholog).
[0063] SEQ ID NO:22 is the cDNA sequence of SEQ ID NO:21.
[0064] SEQ ID NO:23 is the amino acid sequence encoded by SEQ ID NO:22.
[0065] SEQ ID NO:24 is the nucleotide sequence of unmutated GRMZM2G471240-B73.
[0066] SEQ ID NO:25 is the nucleotide sequence of unmutated GRMZM2G471240-RWK.
[0067] SEQ ID NO:26 is the nucleotide sequence of unmutated GRMZM2G471240-ST6.
[0068] SEQ ID NO:27 is the amino acid sequence encoded by SEQ ID NO:24.
[0069] SEQ ID NO:28 is the amino acid sequence encoded by SEQ ID NO:25.
[0070] SEQ ID NO:29 is the amino acid sequence encoded by SEQ ID NO:26.
[0071] SEQ ID NO:30 is the nucleotide sequence of the expression cassette of construct 22466, comprising wild-type MATRILINEAL.
[0072] SEQ ID NO:31 is the nucleotide sequence of the expression cassette of construct 22467, comprising wild-type phosphoglycerate mutase.
[0073] SEQ ID NO:32 is the nucleotide sequence of the expression cassette of construct 22503, comprising a sequence encoding the stem-loop structure of exon 2 targeting MATRILINEAL.
[0074] SEQ ID NO: 33 is the nucleotide sequence of the expression cassette of construct 22513, comprising a sequence encoding a stem-loop structure of exon 4 targeting MATRILINEAL.
[0075] SEQ ID NO:34 is the nucleotide sequence of the expression cassette of construct 22807, comprising sequences encoding the CRISPR / Cas9 editing machinery targeting MATRILINEAL in NP2222.
[0076] SEQ ID NO:35 is the nucleotide sequence of the expression cassette of construct 22808, comprising sequences encoding the CRISPR / Cas9 editing machinery targeting MATRILINEAL in NP2222.
[0077] SEQ ID NO:36 is the nucleotide sequence of the expression cassette of construct 22873, comprising sequences encoding the CRISPR / Cas9 editing machinery targeting MATRILINEAL in NP2222.
[0078] SEQ ID NO:37 is the nucleotide sequence of the expression cassette of construct 23123, comprising sequences encoding the TALEN editing machinery targeting MATRILINEAL in NP2222.
[0079] SEQ ID NO: 38 is the nucleotide sequence of the expression cassette of construct 23501, rice gRNA targeting exon 4 with dual guides.
[0080] SEQ ID NO: 39 is the nucleotide sequence of the expression cassette of construct 23501, with a rice gRNA targeting exon 4 with a single guide.
[0081] SEQ ID NO:40 is the nucleotide sequence of the expression cassette of construct 23501, with a rice gRNA targeting exon 1 with a dual guide.
[0082] SEQ ID NO:41 is the nucleotide sequence of the expression cassette of construct 23501, with a single guide rice gRNA targeting exon 1.
[0083] SEQ ID NO:42 is the nucleotide sequence of the TALEN-induced MTL mutation in event 38A ID 22808-4108 allele 2.
[0084] SEQ ID NO:43 is the nucleotide sequence of the CRISPR-induced MTL mutation in event 27A ID 22807-4073 allele 2.
[0085] SEQ ID NO:44 is the nucleotide sequence of the CRISPR-induced MTL mutation in event 27A ID 22807-4081 allele 2.
[0086] SEQ ID NO:45 is the nucleotide sequence of TILLING strain 1139.
[0087] SEQ ID NO:46 is the nucleotide sequence of TILLING strain 3594.
[0088] SEQ ID NO:47 is the nucleotide sequence of TILLING strain 0505.
[0089] SEQ ID NO:48 is the nucleotide sequence of TILLING strain 2658.
[0090] SEQ ID NO:49 is the nucleotide sequence of TILLING strain 1983.
[0091] SEQ ID NO:50 is the nucleotide sequence of TILLING strain 2732.
[0092] SEQ ID NO:51 is the nucleotide sequence of TILLING strain 2414.
[0093] SEQ ID NO:52 is the amino acid sequence encoded by SEQ ID NO:45.
[0094] SEQ ID NO:53 is the amino acid sequence encoded by SEQ ID NO:46.
[0095] SEQ ID NO:54 is the amino acid sequence encoded by SEQ ID NO:47.
[0096] SEQ ID NO:55 is the amino acid sequence encoded by SEQ ID NO:48.
[0097] SEQ ID NO:56 is the amino acid sequence encoded by SEQ ID NO:49.
[0098] SEQ ID NO:57 is the amino acid sequence encoded by SEQ ID NO:50.
[0099] SEQ ID NO:58 is the amino acid sequence encoded by SEQ ID NO:51.
[0100] SEQ ID NO:59 is the amino acid sequence encoded by SEQ ID NO:9.
[0101] SEQ ID NO:60 is the amino acid sequence encoded by SEQ ID NO:10.
[0102] SEQ ID NO:61 is the amino acid sequence encoded by SEQ ID NO:11.
[0103] SEQ ID NO:62 is the amino acid sequence encoded by SEQ ID NO:12.
[0104] SEQ ID NO:63 is the amino acid sequence encoded by SEQ ID NO:13.
[0105] SEQ ID NO:64 is the amino acid sequence encoded by SEQ ID NO:14.
[0106] SEQ ID NO:65 is the amino acid sequence encoded by SEQ ID NO:15.
[0107] SEQ ID NO:66 is the amino acid sequence encoded by SEQ ID NO:16.
[0108] SEQ ID NO:67 is the amino acid sequence encoded by SEQ ID NO:17.
[0109] SEQ ID NO:68 is the amino acid sequence encoded by SEQ ID NO:18.
[0110] SEQ ID NO:69 is the amino acid sequence encoded by SEQ ID NO:19.
[0111] SEQ ID NO:70 is the amino acid sequence encoded by SEQ ID NO:42.
[0112] SEQ ID NO:71 is the amino acid sequence encoded by SEQ ID NO:43.
[0113] SEQ ID NO:72 is the amino acid sequence encoded by SEQ ID NO:44.
[0114] SEQ ID NO:73 is the amino acid sequence of the MTL ortholog found in Sorghum bicolor.
[0115] SEQ ID NO:74 is the amino acid sequence of the MTL ortholog found in millet (Setaria italica).
[0116] SEQ ID NO:75 is the amino acid sequence of the MTL ortholog found in barley (Hordeum vulgare).
[0117] SEQ ID NO: 76 is the amino acid sequence of the MTL ortholog found in Brachypodium distachyon.
[0118] SEQ ID NO: 77 is the amino acid sequence of the MTL ortholog found in the rice variety Oryza sativa v. indica.
[0119] SEQ ID NO: 78 is the amino acid sequence of the MTL ortholog found in wheat (Triticum aestivum).
[0120] SEQ ID NO: 79 is the amino acid sequence of the MTL ortholog found in Musa acuminata.
[0121] SEQ ID NO: 80 is the amino acid sequence of the MTL ortholog found in oil palm (Elaeis guineensis).
[0122] SEQ ID NO:81 is the amino acid sequence of the MTL ortholog found in Arabidopsis thaliana. BRIEF DESCRIPTION OF THE DRAWINGS
[0123] Figure 1 is a mapping protocol for mapping haploid-induced traits in RWK.
[0124] Figure 2 Shown is the fine mapping that the major QTL is narrowed down to a very small interval (between 67.85Mb and 68.42Mb) in bin 1.04. This region has seven annotated genes. We have sequenced and assembled the genes in this interval in several strains. Two genes with the most significant mutations in the haploid inducer strain are shown in the lower right corner (GRMZM2G471240 and GRMZM2G062320).
[0125] Figure 3GRMZM2G471240 is differentially expressed in haploid inducer and non-inducer pollen and post-anthesis anther sacs (sporophytic tissue with pollen grains removed). This gene is specifically expressed in male gametophytes.
[0126] Figure 4 a shows the splicing-specific qRT-PCR results of GRMZM2G471240. Three biological replicates of R1 stage anthers were tested in technical triplicate, and the mean Ct and standard deviation of each reaction were calculated. The log of ΔCt was used 2 Regression compares the relative amount of each transcript type with endogenous control.Use two groups of primers to assess the relative abundance of each of the two annotation splice variants compared with the unknown primer set about the splice variant.Compared with the long transcripts in NP2222 (wild type) and NP2222-HI (haploid inducer) two genotypes, shorter transcript variants have relatively low abundance.For all three primer pairs tested, the expression of the mutant copy of the gene in NP2222-HI is significantly higher.
[0127] Figure 4 b shows the results from NP2222 and MTL TAL-FS Five biological replicates of fresh pollen from plants (T1 plants homozygous for the edited mtl-like allele) were tested in technical triplicate on universal primers, and the mean Ct and standard deviation were calculated for each reaction. The log of ΔCt was used 2 The regression compared the relative amount of each transcript type to an endogenous control. TAL-FS Pollen had lower transcript abundance than NP2222 (wild type) pollen.
[0128] Figure 5 a shows an amino acid alignment of the B73 predicted protein sequence of the long splice variant of the GRMZM2G471240 gene in B73 and RWK-NIL with the predicted sequence of the mtl allele found in RWK and Stock 6 (S6). Different amino acids are indicated in red; matching amino acids are indicated in normal gray text, and stop codons are indicated by periods. Two point mutations result in amino acid substitutions, histidine (H) for tyrosine (Y), and lysine (K) for arginine (N). These changes are not conservative; it is likely that one or both of these will improve the haploid induction phenotype - indicating that the allelic series may be discovered with further study of the variants.
[0129] Figure 5b shows that wild-type MTL and mutant (truncated) MTL encoded by the mtl allele have in vitro phospholipase activity. PLA2 phospholipase activity was measured by fluorescent liposome assay on recombinant purified proteins produced using MTL and mtl cDNAs. Error bars represent standard errors of the mean based on four replicates.
[0130] Figure 6 mtl is shown to be responsible for the pleiotropic phenotypes associated with haploid induction. 6A: Pollen tube germination rates are similar in inducers and non-inducers (n=200). 6B: Initial pollen tube elongation is also similar (n=25). 6C: RWK but not RWK-NIL is prone to skewed segregation (SD) based on low (25%) trait transmission in germinated progenies (n=300). 6D: The MTL / 0 complement line also shows SD for mtl in germinated progenies (n=400). 6E: A Venn diagram showing the results of RNA-seq analysis of two haploid inducer-near isogenic pairs (left, RWK vs. RWK-NIL; right, NP2222-HI vs. NP2222; red text, upregulated; green text, downregulated). Only 60 genes were found to be significantly changed in the same direction.
[0131] Figure 7Shown is an amino acid alignment of the maize MTL gene with publicly available MTL orthologs in eight grasses, two non-grass monocots, and Arabidopsis thaliana (thale cress). This alignment includes maize (Zea mays), sorghum (Sorghum bicolor, 92% sequence identity to MTL), foxtail millet (Setaria italica, 85% identity), barley (Hordeum vulgare, 78% identity), Brachypodium distachyon (78% identity), Indica and Japonica variety rice (Oryza sativa v. indica and japonica, Os3g27610, 78% and 79% identity, respectively), bread wheat (Triticum aestivum, 55% identity), banana (Musa acuminata, 57% identity), oil palm (Oil palm, 58% identity), and sorghum (Sorghum bicolor, 92% identity to MTL). palm) (Elaeis guineesnsis, 56% identity), and Arabidopsis thaliana (52% identity).
[0132] Figure 8 . Expression profile of rice phospholipase (adapted from Singh, A. et al., Rice phospholipase A superfamily: organization, phylogenetic and expression analysis during abiotic stresses and development, PLOS ONE 7: e30947 (2012)). The closest homolog to MTL is the rice gene
[0133] Fig. 9 . A diagram showing the pathway for editing Os3g27610 to make a haploid inducer line is shown. One can target any part of the gene (shown here - targeting the first and fourth exons) and expect to generate a frameshift mutation that results in gene knockout and loss of function and leads to haploid induction.
[0134] Fig.10 The atomic structure of methyl alpha-linolenoyl fluorophosphonate (MALFP) is shown.
[0135] Fig.11 The atomic structure of methylarachidonyl fluorophosphonate (MAFP) is shown.
[0136] Fig.12 The atomic structure of palmityl trifluoromethyl ketone (PACOCF3) is shown.
[0137] Fig.13 The atomic structure of arachidonyl trifluoromethyl ketone (AACOCF3) is shown.
[0138] Fig.14 The atomic structure of sponge lipids is shown.
[0139] Fig.15 The atomic structure of linoleic acid ethyl ester (LLAEE) is shown.
[0140] Fig.16 The atomic structure of linolenic acid ethyl ester (LNAEE) is shown.
[0141] Fig.17 The atomic structure of arachidonic acid methyl ester (AAME) is shown.
[0142] Fig.18 The atomic structure of oleic acid methyl ester (OAME) is shown.
[0143] Fig.19 The atomic structure of oleic acid ethyl ester (OAEE) is shown.
[0144] Fig. 20 The atomic structure of palmitic acid ethyl ester (PAEE) is shown.
[0145] Fig.21 The atomic structure of palmitoleic acid ethyl ester (PLAEE) is shown.
[0146] Fig. 22 The atomic structure of alpha-linolenic acid (aLNA) is shown.
[0147] Fig.23 The atomic structure of gamma-linolenic acid (gLNA) is shown.
[0148] Fig.24 The atomic structure of oleic acid is shown.
[0149] Fig.25 The atomic structure of linoleic acid is shown.
[0150] Fig.26 The atomic structure of arachidonic acid is shown.
[0151] Fig. 27 The atomic structure of stearic acid is shown.
[0152] Fig.28 The atomic structure of 9(Z)-11(E)-conjugated linoleic acid is shown.
[0153] Fig.29 The atomic structure of distearoylphosphatidylcholine (DSPC) is shown.
[0154] Fig.30 The atomic structure of 2-oleoyl-1-palmitoyl-sn-glycero-3-phospho-ethanolamine is shown.
[0155] Fig.31 The generic atomic structure of a molecule operable in the claimed invention is shown.
[0156] definition
[0157] While it is believed that the following terms are well understood by those of ordinary skill in the art, the following definitions are set forth to facilitate explanation of the subject matter disclosed herein.
[0158] Unless otherwise defined, all technical and scientific terms used herein are intended to have the same meaning as those generally understood by those of ordinary skill in the art. References to the technology employed herein are intended to reference technology generally understood in the art, including variations of those technologies and / or replacement of equivalent technologies that are well known to those of ordinary skill in the art. Although it is believed that the following terms may be well understood by those of ordinary skill in the art, the following definitions are provided for ease of explanation of the subject matter disclosed in this application.
[0159] In accordance with long-standing patent law conventions, the terms "a," "an," and "the" as used in this application, including the claims, mean "one or more." For example, the phrase "a cell" refers to one or more cells, and in some embodiments may refer to tissues and / or organs. Similarly, the phrase "at least one," when used herein to refer to an entity, refers to, for example, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 15, 20, 25, 30, 35, 40, 45, 50, 75, 100 or more of the entity, including, but not limited to, all integer values between 1 and 100 and integers greater than 100.
[0160] Unless otherwise indicated, all numbers used in the specification and claims expressing amounts of ingredients, reaction conditions, and the like are to be understood as modified in all instances by the term "about". As used herein, the term "about", when referring to a measurable value such as an amount of mass, weight, time, volume, concentration, or percentage, is meant to encompass variations of ±20% from the specified amount in some embodiments, ±10% from the specified amount in some embodiments, ±5% from the specified amount in some embodiments, ±1% from the specified amount in some embodiments, ±0.5% from the specified amount in some embodiments, and ±0.1% from the specified amount in some embodiments, as such variations are suitable for performing the disclosed methods and / or using the disclosed compositions, nucleic acids, polypeptides, and the like. Therefore, unless indicated to the contrary, the numerical parameters listed in the specification and the appended claims are approximate values that may vary depending on the desired properties sought to be obtained by the subject matter disclosed in the present application.
[0161] As used herein, the term "allele" refers to a variant or alternative sequence form at a genetic locus. In a diploid, at each locus, a single allele is inherited from each parent to an offspring individual. The two alleles present in a given locus in a diploid organism occupy corresponding positions on a pair of homologous chromosomes, although those of ordinary skill in the art understand that the alleles in any particular individual do not necessarily represent all the alleles present in the species.
[0162] As used herein, the term "and / or," when used in the context of a list of entities, refers to the entities as being present individually or in combination. Thus, for example, the phrase "A, B, C, and / or D" includes A, B, C, and D individually, but also includes any and all combinations and subcombinations of A, B, C, and D (e.g., AB, AC, AD, BC, BD, CD, ABC, ABD, and BCD). In some embodiments, one or more elements referred to by "and / or" may also be present individually in single or multiple occurrences in combinations and / or subcombinations.
[0163] As used herein, the phrase "related to..." refers to the identifiable and / or measurable relationship between two entities. For example, the phrase "related to HI" refers to proterties, locus, gene, allele, mark, phenotype, etc. or its expression, and their presence or absence can affect the scope and / or degree of HI performance of plants or their offspring. Therefore, when the marker is linked to the proterties and when the presence of the mark indicates whether the desired proterties or proterties form will and / or will occur in the plant / germplasm comprising the mark to what extent, the marker is "related" to the proterties. Similarly, when the marker is linked to the allele and when the presence of the mark indicates whether the allele is present in the plant / germplasm comprising the mark, the marker is "related" to the allele. For example, "the mark related to HI" refers to that its presence or absence can be used to predict whether the plant will and / or will show the mark of haploid induction to what extent.
[0164] The term "comprising" is synonymous with "including," "containing," and "characterized by," is inclusive or open-ended, and does not exclude additional, unrecited elements and / or method steps. "Comprising" is a term that means the specified elements and / or steps are present, but other elements and / or steps may be added and still fall within the scope of the relevant subject matter.
[0165] As used herein, the phrase "consisting of excludes any element, step or ingredient not specifically recited. When the phrase "consisting of" appears in a clause of the body of a claim, rather than immediately following the preamble, it limits only the elements set forth in that clause; other elements are not excluded from the entire claim.
[0166] As used herein, the phrase "consisting essentially of limits the scope of the associated disclosure or claim to the specified materials or steps, plus those that do not materially affect the basic and novel characteristics of the disclosed and / or claimed subject matter.
[0167] With respect to the terms "comprising," "consisting essentially of," and "consisting of," where one of these three terms is used herein, the subject matter disclosed and claimed in the present application may, in some embodiments, include the use of either of the other two terms. For example, if the subject matter, in some embodiments, relates to a nucleic acid encoding a polypeptide comprising an amino acid sequence having at least 95% identity to SEQ ID NO: 2 or 3. It should be understood that the disclosed subject matter therefore also encompasses nucleic acids encoding polypeptides consisting essentially of an amino acid sequence having at least 95% identity to SEQ ID NO: 2 or 3, and nucleic acids encoding polypeptides consisting of an amino acid sequence having at least 95% identity to SEQ ID NO: 2 or 3, in some embodiments. Similarly, it should also be understood that in some embodiments, the methods for the disclosed subject matter include the steps disclosed herein, in some embodiments, the methods for the subject matter disclosed in the present application consist essentially of the disclosed steps, and in some embodiments, the methods for the subject matter disclosed in the present application consist of the steps disclosed herein.
[0168] As used herein, the term "de novo haploid induction" refers to triggering haploid induction by introducing a spontaneous haploid induction agent. Such introduction can be achieved by topical spraying, manual pollination, mutagenesis or transgenic methods. Throughout this specification, the terms "de novo haploid induction", "de novo HI" and "haploid induction de novo" are used interchangeably.
[0169] As used herein, the term "gene" refers to a unit of inheritance comprising a DNA sequence that occupies a specific location on a chromosome and contains the genetic instructions for a specific characteristic or trait in an organism.
[0170] A "genetic map" is a description, usually depicted in graphical or tabular form, of the genetic linkage relationships between loci on one or more chromosomes within a given species.
[0171] As used herein, the plant referred to as "haploid" has a single set of (genome) chromosomes, and the number of chromosomes (n) reduced in the haploid plant is equal to the number of gametes. As used herein, the plant referred to as "double haploid" is developed by doubling the haploid chromosome set. Plants or seeds obtained from selfing to any number of generations of double haploid plants can still be identified as double haploid plants. Double haploid plants are considered to be homozygous plants. If the plant is fertile, even if the entire vegetative part of the plant does not contain cells with double sets of chromosomes, the plant is also considered to be double haploid; that is, if the plant contains surviving gametes, even if it is mosaic, it will also be considered to be double haploid.
[0172] As used herein, the term "human-induced mutation" refers to any mutation that occurs due to direct or indirect human action. This term includes, but is not limited to, mutations obtained by any directed mutagenesis method.
[0173] As used herein, the terms "label probe" and "probe" refer to a nucleotide sequence or nucleic acid molecule that can be used to detect the presence or absence of a sequence within a larger sequence (e.g., a nucleic acid probe that is complementary to all or part of a marker or marker locus by nucleic acid hybridization). Label probes comprising about 8, 10, 15, 20, 30, 40, 50, 60, 70, 80, 90, 100 or more consecutive nucleotides can be used for nucleic acid hybridization.
[0174] As used herein, when identifying the presence / absence of the locus associated with HI, the term "molecular marker" can be used to refer to genetic markers as defined above, or it can be used as a coded product (e.g., protein) of a reference point. Molecular markers can be derived from a genomic nucleotide sequence or an expressed nucleotide sequence (e.g., from RNA, cDNA, etc.). The term also refers to a nucleotide sequence complementary to a marker sequence or with its side joint, such as a nucleotide sequence used as a probe or primer that can amplify a marker sequence. When a nucleotide sequence is specifically hybridized in a solution, the nucleotide sequence is "complementary" (e.g., according to Watson-Crick base pairing principle). This term also refers to a genetic marker that does not exist to indicate a trait by a nucleotide sequence complementary to a marker sequence or with its side joint (e.g., a nucleotide sequence used as a probe or a primer that can amplify a marker sequence).
[0175] As used herein, the terms "nucleotide sequence", "polynucleotide", "nucleic acid sequence", "nucleic acid molecule", and "nucleic acid fragment" refer to a polymer of single-stranded or double-stranded RNA or DNA, optionally containing synthetic, non-natural, and / or altered nucleotide bases. A "nucleotide" is a monomeric unit from which a DNA or RNA polymer is constructed and consists of a purine or pyrimidine base, a pentose, and a phosphate group. Nucleotides (usually found in their 5'-monophosphate form) are referred to by their single-letter nomenclature as follows: "A" is adenylic acid or deoxyadenylic acid (for RNA or DNA, respectively), "C" is cytidylic acid or deoxycytidylic acid, "G" is guanylic acid or deoxyguanylic acid, "U" is uridylic acid, "T" is deoxythymidylic acid, "R" is a purine (A or G), "Y" is a pyrimidine (C or T), "K" is G or T, "H" is A or C or T, "I" is inosine, and "N" is any nucleotide.
[0176] As used herein, the term "nucleotide sequence identity" refers to the presence of consistent nucleotides at the corresponding positions of two polynucleotides. When comparison is performed to obtain maximum correspondence (for example, in a comparison window), if the nucleotide sequence in two polynucleotides is identical, the polynucleotide has a "consistent" sequence. The sequence comparison between two or more polynucleotides is usually performed by comparing the parts of the two sequences on a comparison window to identify and compare the local region of sequence similarity. The comparison window is typically from about 20 to 200 continuous nucleotides. The "sequence identity percentage" of a polynucleotide, such as about 50%, 55%, 60%, 65%, 70%, 75%, 80%, 85%, 90%, 95%, 98%, 99% or 100% sequence identity, can be determined by comparing the sequences of two optimal comparisons on a comparison window, wherein for the optimal comparison of two sequences, compared with a reference sequence, the part of the polynucleotide sequence in the comparison window can include addition or deletion (that is, room). In some embodiments, the percentage is calculated by: (a) determining the number of positions at which consistent nucleic acid bases appear in the two sequences; (b) dividing the number of matching positions by the total number of positions in the comparison window; and (c) multiplying the result by 100. The optimal alignment of the sequences for comparison can also be performed by computerized implementation of known algorithms or by visual inspection. Easily available sequence comparison and multiple sequence alignment algorithms are the Basic Local Alignment Search Tool (BLAST) and ClustalW / ClustalW2 / Clustal Omega programs available on the Internet (e.g., the website of EMBL-EBI). Other suitable programs include, but are not limited to, GAP, BestFit, Plot Similarity and FASTA, which are part of the Accelrys GCG software package available from Accelrys (San Diego, California, USA). See also Smith and Waterman, 1981; Needleman and Wunsch, 1970; Pearson and Lipman, 1988; Ausubel et al., 1988; and Sambrook and Russell, 2001.
[0177] An example of an algorithm suitable for determining percent sequence identity and sequence similarity is the BLAST algorithm, which is described in Altschul et al., 1990. In some embodiments, the percent sequence identity refers to the sequence identity over the entire length of one of the gDNA, cDNA, or predicted protein sequences in the largest ORF of SEQ ID No: 1 being compared. In some embodiments, the calculation for determining the percent nucleic acid sequence identity does not include in the calculation any nucleotide position where one of the compared nucleic acids includes an "N" (i.e., where any nucleotide may be present at that position).
[0178] The term "open reading frame" (ORF) refers to a nucleic acid sequence encoding a polypeptide. In some embodiments, an ORF comprises a translation initiation codon, a translation termination (termination) (i.e., stop) codon, and a nucleic acid sequence encoding amino acids present in the polypeptide therebetween. The terms "start codon" and "stop codon" refer to a unit of three adjacent nucleotides (i.e., codons) in a coding sequence, which correspondingly indicate the start and chain termination of protein synthesis (mRNA translation).
[0179] The potato protein-like phospholipase A2α may also be referred to as PLA, pPLA, pPLAIIA pPLAIIα, PLA2α, or PLA2, or other similar variants. The potato protein-like phospholipase AIIα is also referred to as MATRILINEAL. These terms are used interchangeably throughout. The MATRILINEAL gene containing the four base pair frameshift mutation is hereby named matrilineal.
[0180] As used herein, the term "phenotype", "phenotypic traits" or "traits" refers to one or more traits of a plant or plant cell. Phenotype is observable for the naked eye or by any other evaluation means known in the art (e.g., microscopy, biochemical analysis, or electromechanical determination). In some cases, phenotype is directly controlled by a single gene or genetic locus (i.e., corresponding to a "single gene trait"). In the case of haploid induction, a color marker (e.g., R Navajo) and other markers (including a transgenic visualized by the presence or absence of color in the seed) are used to prove whether the seed is an induced haploid seed. Using R Navajo as a color marker and using transgenic as a means of detecting haploid seed induction on a female plant is well known in the art. In other cases, phenotype is the result of the interaction between several genes, and in some embodiments, it is also caused by plant and / or plant cell interacting with its environment.
[0181] As used herein, the term "plant" can refer to a whole plant, any part thereof, or a cell or tissue culture derived from a plant. Thus, the term "plant" can refer to any of a whole plant, a plant component or organ (e.g., leaves, stems, roots, etc.), a plant tissue, a seed, and / or a plant cell.
[0182] Plant cells are plant cells obtained from plants, or plant cells derived from cells taken from plants by culture. Thus, the term "plant cell" includes, but is not limited to, cells within seeds, suspension cultures, embryos, meristems, callus, leaves, shoots, gametophytes, sporophytes, pollen, and microspores. The phrase "plant part" refers to a part of a plant, including single cells and cell tissues (e.g., intact plant cells in plants), cell clumps, and tissue cultures that can regenerate plants. Examples of plant parts include, but are not limited to, single cells and tissues from pollen, ovules, leaves, embryos, roots, root tips, anthers, flowers, fruits, stems, shoots, and seeds; as well as scions, rhizomes, protoplasts, callus, and the like.
[0183] As used herein, the term "primer" refers to an oligonucleotide that, when placed under conditions that induce synthesis of a primer extension product (e.g., in the presence of nucleotides and an agent for polymerization (such as a DNA polymerase) and at a suitable temperature and pH), is capable of annealing to a nucleic acid target (in some embodiments, specifically annealing to a nucleic acid target), allowing a DNA polymerase and / or reverse transcriptase to attach thereto, thereby serving as a starting point for DNA synthesis. In some embodiments, one or more primers are employed to amplify nucleic acids (e.g., using a polymerase chain reaction; PCR).
[0184] As used herein, the term "probe" refers to a nucleic acid (e.g., a single-stranded nucleic acid or a double-stranded or higher-order nucleic acid chain, or a subsequence thereof) that can form a hydrogen-bonded duplex with a complementary sequence in a target nucleic acid sequence. Typically, the probe has a sufficient length to form a stable and sequence-specific duplex molecule with its complementary sequence, and can be used in some embodiments to detect a sequence of interest present in a plurality of nucleic acids.
[0185] As used herein, the terms "offspring" and "offspring plant" refer to plants produced by asexual or sexual reproduction from one or more parent plants. In haploid induction, the seeds on the maternal parent are haploid and are therefore not offspring of the induced haploid line. The offspring of haploid seeds are not the only desired offspring. There are also subsequent plants and seed offspring of HI seeds and haploid induced plants. Both haploid seeds and HI seeds can be offspring. Offspring plants can be obtained by cloning a single parent plant or selfing a single parent plant, or by hybridizing two or more parent plants. For example, offspring plants can be obtained by cloning a single parent plant or selfing a single parent plant, or by hybridizing two parent plants, and include selfings and F 1 or F 2 Or even further generations. 1 are the first generation of offspring produced from the parents (at least one of these parents is used as a donor for the trait for the first time), while the second generation (F 2) or subsequent generations (F 3 、F 4 etc.) are descended from F 1 、F 2 Specimens produced by selfing, intercrossing, backcrossing and / or other hybridization. 1 can be (and in some embodiments is) a hybrid produced from a cross between two true breeding parents (i.e., each of the true breeding parents is homozygous for the trait of interest or its alleles), and F 2 It can be (and in some embodiments is) from F 1 The offspring of a hybrid produced by self-pollination.
[0186] As used herein, phrase "recombination" refers to the exchange ("interchange") of DNA fragments between two DNA molecules or chromatids of paired chromosomes in a region of similar or identical nucleotide sequences."Recombination event" is understood herein to refer to meiotic interchange in some embodiments.
[0187] As used herein, the term "reference sequence" refers to a determined nucleotide sequence used as a basis for nucleotide sequence comparison. In some embodiments, any one of SEQ ID NOs: 1-4, 22-23, or 73-81 can be used as a reference sequence for comparison with other sequences obtained from plants.
[0188] As used herein, the term "regeneration" and grammatical variations thereof refer to the production of plants from tissue culture.
[0189] As used herein, the phrase "stringent hybridization conditions" refers to conditions under which a polynucleotide will typically hybridize to its target subsequence (but not substantially to other sequences) in a complex mixture of nucleic acids. Stringent conditions are sequence-dependent and may be different in different circumstances.
[0190] Typically, longer sequences hybridize specifically at higher temperatures. An extended guide to nucleic acid hybridization is found in Sambrook and Russell, 2001. In general, stringent conditions are selected to be below the thermodynamic melting point (T) for the specific sequence at a defined ionic strength and pH. m) about 5°C-10°C. Tm is the temperature (under defined ionic strength, pH, and nucleic acid concentration) at which 50% of the probes complementary to the target hybridize to the target sequence at equilibrium (when the target sequence is present in excess, at Tm, 50% of the probes are occupied at equilibrium). Exemplary stringent conditions are those with a salt concentration of less than about 1.0 M sodium ion, typically about 0.01 M to 1.0 M sodium ion concentration (or other salts) at pH 7.0 to 8.3, and a temperature of at least about 30°C for short probes (e.g., 10 to 50 nucleotides) and at least about 60°C for long probes (e.g., greater than 50 nucleotides).
[0191] Stringent conditions can also be achieved by adding destabilizing agents such as formamide. Additional exemplary stringent hybridization conditions include 50% formamide, 5x SSC and 1% SDS, incubated at 42°C; or SSC, 1% SDS, incubated at 65°C; washed once or multiple times in 0.2x SSC and 0.1% SDS at 65°C. For PCR, a temperature of about 36°C is typically used for low stringency amplification, but depending on the primer length, the annealing temperature can vary between about 32°C and 48°C (or higher). Additional guidelines for determining hybridization parameters are provided in many references (see, for example, Ausubel et al., 1999).
[0192] As used herein, the term "trait" refers to a phenotype of interest, a gene that contributes to a phenotype of interest, and a nucleic acid sequence associated with a gene that contributes to a phenotype of interest. For example, an "HI trait" refers to a haploid-induced phenotype, and a gene that contributes to haploid induction and a nucleic acid sequence associated with the presence or absence of a haploid-induced phenotype (e.g., a HI-associated gene product).
[0193] As used herein, the term "transgenic" refers to a nucleic acid molecule introduced into an organism or one or more of its ancestors by some form of artificial transfer technology. Therefore, artificial transfer technology produces a "transgenic organism" or "transgenic cell". It should be understood that artificial transfer technology can occur in an ancestral organism (or a cell therein and / or a cell that can develop into an ancestral organism), and even if one or more natural and / or assisted breeding results in the presence of an artificially transferred nucleic acid molecule in an offspring individual, any offspring individual with an artificially transferred nucleic acid molecule or a fragment thereof is still considered to be transgenic.
[0194] As used herein, the term "directed mutagenesis" or "mutagenesis strategy" refers to any mutagenesis method that results in the deliberate mutagenesis of a selected gene. Directed mutagenesis includes the methods CRISPR, TILLING, TALEN, and other methods that have not yet been discovered but can be used to achieve the same results.
[0195] As used herein, haploid induction rate ("HIR") means the number of haploid kernels that survive pollination of an ear with haploid inducer pollen divided by the total number of kernels.
[0196] Specific problems plague haploid induction: increased embryo abortion rates and increased fertilization failure rates (reduced seed set rates). For these reasons, there is a need to successfully determine the causes of HI and use this knowledge to determine methods to stably or increasingly produce haploid plants while reducing fertilization failure and embryo abortion.
[0197] It is particularly contemplated that one can mutagenesis promoters to potentially improve the effectiveness of elements for expressing transgenics in plants. Mutagenesis of these elements can be performed randomly, and the activity of the mutated promoter sequence can be screened in a trial-by-error procedure. Alternatively, a specific sequence that provides a desired expression characteristic or expression enhancing activity can be identified as a promoter, and these or similar sequences can be introduced into the promoter via mutation. It is further contemplated that one can mutagenesis these sequences in order to enhance the expression of its transgenics in a particular species. The means for mutagenesis of the DNA segment encoding the promoter sequence of the present invention are well known to those skilled in the art. As indicated, promoters or other regulatory elements can be modified by random or site-specific mutagenesis procedures. Promoters and other regulatory elements can be modified by changing their structure by adding or deleting one or more nucleotides from the sequence encoding the corresponding unmodified sequence.
[0198] Mutagenesis can be carried out according to any technique known in the art, such as but not limited to synthesizing oligonucleotides with one or more mutations in the sequence of a specific regulatory sequence. Specifically, site-specific mutagenesis is a technique that can be used to prepare promoter mutants by specific mutagenesis of basic DNA. RNA-guided endonucleases ("RGEN", such as CRISPR / Cas9) can also be used. For example, in conjunction with one or more of the aforementioned considerations, by introducing one or more nucleotide sequence changes into DNA, the technology further provides the ready-made ability to prepare and test sequence variants. Site-specific mutagenesis allows the use of specific oligonucleotide sequences of the DNA sequence encoding the desired mutation and a sufficient number of adjacent nucleotides to provide primer sequences of sufficient size and sequence complexity to form stable duplexes on both sides of the deletion connection fragment being studied in detail and produce mutants. Typically, primers of about 17 to about 75 nucleotides or more nucleotides in length are preferred, wherein about 10 to about 25 or more residues on both sides of the sequence connection fragment are changed.
[0199] In the case of isolating clones containing promoters according to the present invention, people may wish to define the basic promoter region within the clone. An effective targeting means for preparing a mutagenic promoter relies on identifying inferred regulatory elements within the promoter sequence. This can be initiated by comparing with promoter sequences known to be expressed with similar tissue specificity or developmental unique patterns. Sequences shared between promoters with similar expression patterns may be candidates for transcription factor binding, and therefore may be elements that confer expression patterns. The confirmation of these inferred regulatory elements can be performed by deletion analysis of each inferred regulatory sequence, followed by functional analysis of each deletion construct by measuring the reporter gene functionally attached to each construct to achieve. Therefore, once the starting promoter sequence is provided, any one of the many different deletion mutants of the starting promoter can be easily prepared.
[0200] The invention disclosed herein provides polynucleotide molecules comprising regulatory element fragments that can be used to construct novel chimeric regulatory elements. Novel combinations of fragments comprising these polynucleotide molecules and at least one other regulatory element or fragment can be constructed and tested in plants and are considered to be within the scope of the present invention. Therefore, the design, construction and use of chimeric regulatory elements are an embodiment of the present invention. Promoters of the present invention include homologs of cis elements that show homology to the promoter sequence of the present invention, known to affect gene regulation.
[0201] The functional equivalent fragment of one of transcription regulating nucleic acid described herein comprises the transcription regulating nucleic acid of at least 50,100,150,200,250,300,350,400,450,500,550,600,650,700,750,800,850,900,950 or 1000 base pairs.Then, the equivalent fragment of the transcription regulating nucleic acid obtained by the region of the 5' non-translated region of the missing coding mRNA will only provide (untranscribed) promoter region.5' non-translated region can be easily determined by methods known in the art (such as 5'-RACE analysis).Therefore, some transcription regulating nucleic acids described herein are equivalent fragments of other sequences.
[0202] As indicated above, the deletion mutants of promoter of the present invention can also be prepared randomly and then measured. According to this strategy, a series of constructs are prepared, each construct contains the different parts (subclones) of promoter, and then the activity of these constructs is screened. Suitable means for screening activity is to attach the deletion promoter or intron construct containing the deletion section to selectable or screenable markers, and only separate those cells of expression marker genes. In this way, many different, deletion promoter constructs have been identified, which still retain the activity of hope or even enhancement. Thus, the minimum section required for activity is identified by comparing the selected construct. Then, this section can be used to build a carrier for expressing foreign genes.
[0203] Expression cassette as described herein can comprise other regulating elements.The term in this context should be broadly understood to comprise all sequences that can affect the structure or function of expression cassette.For example, regulating elements can modify transcription and / or translation in prokaryotic organisms or eukaryotic organisms.Expression cassette as described herein can be downstream (in 3 ' direction) of nucleotide sequence to be expressed and optionally contain other regulating elements, such as transcription or translation enhancer.Each other regulating element can be operably connected to nucleotide sequence to be expressed (or transcription regulating nucleotide sequence).Other regulating elements can comprise other promoters, minimal promoters, promoter elements or transposon elements that can modify or enhance expression regulating properties.Expression cassette can also contain one or more introns, one or more exons and one or more terminators.
[0204] In addition, it is considered that promoter combinations from elements of more than one promoter may be useful. For example, U.S. Patent number 5,491,288 discloses combining a cauliflower mosaic virus promoter with a histone promoter. Therefore, elements from promoters disclosed herein can be combined with elements from other promoters. Promoters that can be used for plant transgenic expression include inducible, viral, synthetic, composed (Odell Nature [Nature] 313: 810-812 (1985)), time-regulated, spatially regulated, tissue-specific and space-time regulated promoters. Using regulatory elements as described herein, many agronomy genes can be expressed in transformed plants. More specifically, plant genetic engineering can be used to express various phenotypes of interest in agronomy.
[0205] The compounds of the present invention can exist in different geometric or optical isomers (diastereomers and enantiomers) or tautomeric forms. The present invention encompasses all such isomers and tautomers and their mixtures in all proportions, together with isotopic forms, such as deuterated compounds. The present invention also encompasses all salts, N-oxides, and metalloid complexes of the compounds of the present invention.
[0206] Each alkyl moiety, alone or as part of a larger group (e.g., alkoxy, alkoxycarbonyl, alkylcarbonyl, alkylaminocarbonyl, dialkylaminocarbonyl), is linear or branched and is, for example, methyl, ethyl, n-propyl, n-butyl, n-pentyl, n-hexyl, isopropyl, n-butyl, sec-butyl, isobutyl, tert-butyl, or neopentyl. Alkyl groups include C1-C6 alkyl, C1-C4 alkyl, and C1-C3 alkyl.
[0207] As used herein, the term "alkenyl" is an alkyl moiety having at least one carbon-carbon double bond, such as C2-C6 alkenyl. Specific examples include vinyl and allyl. The alkenyl moiety can be part of a larger group (e.g., alkenyloxy, alkenyloxycarbonyl, alkenylcarbonyl, alkenylaminocarbonyl, dienylaminocarbonyl).
[0208] The term "acetoxy" refers to -OC(=O)CH3.
[0209] As used herein, the term "alkynyl" is an alkyl moiety having at least one carbon-carbon triple bond, such as C2-C6 alkynyl. Specific examples include ethynyl and propargyl. The alkynyl moiety can be part of a larger group (e.g., alkynyloxy, alkynyloxycarbonyl, alkynylcarbonyl, alkynylaminocarbonyl, dialkynylaminocarbonyl).
[0210] Halogen is fluorine (F), chlorine (Cl), bromine (Br) or iodine (I).
[0211] A haloalkyl group (alone or as part of a larger group such as haloalkoxy or haloalkylthio) is an alkyl group substituted by one or more halogen atoms which may be the same or different, and is, for example, -CF3, -CF2Cl, -CH2CF3 or -CH2CHF2.
[0212] A hydroxyalkyl group is an alkyl group substituted by one or more hydroxy groups and is, for example, -CH2OH, -CH2CH2OH or -CH(OH)CH3.
[0213] An alkoxyalkyl group is an alkoxy group (RO-R') bonded to an alkyl group, for example -(CH2) r O(CH2) s CH3, wherein r is 1-6, and s is 1-5.
[0214] In the context of the present specification, the term "aryl" refers to a ring system which may be monocyclic, bicyclic or tricyclic. Examples of such rings include phenyl, naphthyl, anthracenyl, indenyl or phenanthrenyl.
[0215] Unless otherwise indicated, alkenyl and alkynyl (by themselves or as part of another substituent) may be straight or branched, and may contain 2 to 6 carbon atoms, and may be in the (E) or (Z) configuration where appropriate. Examples include vinyl, allyl, ethynyl and propargyl.
[0216] Unless otherwise indicated, cycloalkyl may be monocyclic or bicyclic, may be optionally substituted with one or more C1-C6 alkyl groups, and contain 3 to 7 carbon atoms. Examples of cycloalkyl include cyclopropyl, 1-methylcyclopropyl, 2-methylcyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl.
[0217] The term "heterocyclyl" refers to a ring system containing from 1 to 4 heteroatoms selected from N, O and S, wherein the nitrogen and sulfur atoms are optionally oxidized, and the nitrogen atom is optionally quaternized. Heterocyclyl includes heteroaryl, saturated analogs and also their unsaturated or partially unsaturated analogs, such as 4,5,6,7-tetrahydro-benzothienyl, 9H-fluorenyl, 3,4-dihydro-2H-benzo-1,4-dioxepyl, 2,3-dihydro-benzofuranyl, piperidinyl, 1,3-dioxolanyl, 1,3-dioxanyl, 4,5-dihydro-isoxazolyl, tetrahydrofuranyl and morpholinyl. In addition, the term "heterocyclyl" includes heterocycloalkyl, a non-aromatic monocyclic or polycyclic ring containing carbon atoms and hydrogen atoms and at least one heteroatom selected from nitrogen, oxygen and sulfur, such as oxetanyl or thietanyl. Monocyclic heterocycloalkyl groups may contain 3 to 7 members.
[0218] The term "heteroaryl" refers to an aromatic ring system containing from 1 to 4 heteroatoms selected from N, O and S, wherein the nitrogen and sulfur atoms are optionally oxidized, the aromatic ring system having, for example, 5, 6, 9, or 10 members and consisting of a monocyclic ring or consisting of two or more fused rings. The monocyclic ring may contain up to three heteroatoms, and the bicyclic system contains up to four heteroatoms, which will preferably be selected from nitrogen, oxygen and sulfur. Examples of such groups include pyridyl, pyridazinyl, pyrimidinyl, pyrazinyl, furanyl, thienyl, oxazolyl, isoxazolyl, oxadiazolyl, thiazolyl, isothiazolyl, thiadiazolyl, pyrrolyl, pyrazolyl, imidazolyl, triazolyl and tetrazolyl.
[0219] Examples
[0220] I. Identification of frameshift mutations in PLA
[0221] The present invention identifies a series of independent human-induced mutations found in at least one patatin-like phospholipase AIIα (pPLAIIα) gene of maize; maize plants having these mutations in at least one PLA gene; and methods for generating and identifying similar and / or additional mutations in PLA genes by screening pooled and / or individual rice and maize plants. The rice and maize plants of the present invention have induced haploidy due to non-transgenic mutations in at least one PLA gene.
[0222] More specifically, the present invention produces new maize haploid induced lines. There are many known haploid induced maize lines, including but not limited to: Stock 6, MHI (Moldova haploid inducer), indeterminate gametophyte ("ig") mutation, KEMS, ZEM, ZMS, KMS, RWS and RWK. The present invention relates to methods for identifying and / or selecting germplasm that can or cannot induce haploids. The present invention also relates to increasing and further developing selected haploid induced germplasm. The present invention further relates to methods for improving haploid induced germplasm to increase haploid induction on seed producing parents.
[0223] The initial step of producing haploid seeds from hybrid or separated maternal plants is derived from pollination on the ear from seed production plants with pollen from haploid inducers. The result of this hybridization process is to produce diploid and maternal haploid (1n) grains. The haploid (1n) grains of induction are usually distinguished from diploid seeds by using color markers indicating embryo ploidy. Diploid seeds are usually discarded, and haploid grains or embryos usually undergo chromosome doubling process to produce double haploid plants. More specifically, haploid genetic material is processed with one or more mitotic blockers to allow the haploid (1n) chromosome set in one or more cells to produce homolog pairs. After the chemical treatment procedure, the chromosome doubling chemicals are removed. Allow the present double haploid corn to mature, and the double haploid seeds produced when planting will produce homozygous plants (also referred to as inbred plants or strains). These inbred strains are materials that breeders use to pursue hybrid development projects.
[0224] The loci for the haploid induction trait have been finely mapped. Although the major QTL on chromosome 1 responsible for haploid induction has been mapped and published (Dong et al. Theor. Appl. Genet [Theory and Application of Genetics] (2013) 126: 1713-1720), the exact gene / genetic element responsible for the induction process has not been identified until now. In order to elucidate the developmental genetics underlying haploid induction, the Stock 6 derivative RWK (about 13% HIR) was obtained from the University of Hohenheim in 2006, crossed with the inbreds NP2460 and NP2391, and subsequently backcrossed with RWK to generate a mapping population. See Figure 1 .
[0225] Elevated HIR in both populations co-segregated with marker SM020SDQ in bin 1.04, consistent with a recent report on a QTL termed qhir1. See Prigge et al., New Insights into the Genetics of in Vivo Induction of Maternal Haploids, the Backbone of Doubled Haploid Technology in Maize, GENETICS (2012) 190:781-793 (discussing the major QTL for HI in Bin 1.04 [qhir1] and the minor QTLs for HI in Bin 3.02 [qhir2], Bin 3.06 [qhir3], Bin 4.03 [qhir4], Bin 5.01 [qhir5], Bin 5.04 [qhir6], Bin 7.01 [qhir7], and Bin 9.01 [qhir8]); Liu et al., Fine mapping of qhir8 affecting in vivo haploid induction in maize. maize [Fine Mapping of qhir8 Affecting Haploid Induction in Maize], THEOR.APPL.GENET [Theoretical and Applied Genetics] (2015) 128:2507–2515 (fine mapping of thirty-five genes to qhir8); Hu et al., The Genetic Basis of Haploid Induction in Maize Identified with a Novel Genome-Wide Association Method [The Genetic Basis of Haploid Induction in Maize Identified with a Novel Genome-Wide Association Method], GENETICS [Genetics] (2016) 202:1267–1276 (asserting that qhir1 is two QTLs: qhir11 and qhir12, and fine mapping qhir6 to a 1.1 Mb region). We performed several rounds of fine mapping and narrowed the QTL to a region of approximately 0.57 Mb between 67.85 Mb and 68.42 Mb just within qhir11. This region has seven annotated genes ( Figure 2 ).
[0226] Using Illumina HiSeq2000, we sequenced the following: RWK, Stock6, and the BC3F5 non-inducer "RWK-NIL" which is nearly isogenic to RWK but has the NP2391 haplotype in the qhir11 interval. By comparing the inducer and non-induced germplasm, it was determined that the four nucleotide insertions present in the haploid inducer were not present in the non-induced germplasm, and the nucleotide insertions shifted the amino acid coding frame of GRMZM2G471240. Therefore, the present invention identifies genes with frameshift mutations in the inducer germplasm as responsible for maize haploid induction. The candidate gene corresponding to the gene model GRMZM2G471240 encodes potato glycoprotein-like phospholipase AIIα (pPLAIIα), which we renamed MATRILINEAL (MTL) to represent the wild-type allele, and the frameshift allele is called matrilineal (mtl).
[0227] For each candidate gene, DNA sequences were generated from two induced lines (Stock6 and RWK) and one non-induced line (RWK-NIL). In addition, public B73 genome data was used as a second non-induced line. Gene model information was compared with EST / cDNA data to confirm the structure of each gene. Annotated sequence data were compared with the catalog differences between the four alleles of each gene.
[0228] Sequence comparison revealed that the B73 and RWK-NIL alleles are similar to each other, and the RWK and Stock 6 alleles are similar to each other. Most of the sequence differences are single nucleotide polymorphisms that do not alter protein coding sequences. There are some insertions and some deletions, most of which are in non-protein coding sequences.
[0229] Table 1 below lists the gene identities in the indicated intervals. This information is from chromosome 1, see, e.g., Patrick S. Schnable et al., The B73 Maize Genome: Complexity, Diversity, and Dynamics, 326 SCIENCE 1112-15 (2009), which is incorporated herein by reference in its entirety, and lists a brief description of other encoded proteins from genes within the haploid inducing locus.
[0230]
[0231]
[0232] After completing fine mapping of the haploid inducer trait to an interval containing only seven genes, we focused on those in the sequence assembly and analysis. The sequences of the seven genes were nearly identical between B73 and RWK-NIL, but RWK and Stock6 lacked GRMZM2G062320 (phosphoglycerate mutase (PGM)) and had a 4 base pair ("bp") insertion in the fourth exon of GRMZM2G471240 (potatoin-like phospholipase AIIα (pPLAIIα)). Figure 2 ). We found that both RWK and Stock6 have the same 4 bp insertion in the fourth exon of pPLAIIα, and this gene is specifically expressed in pollen (see maizegdb.org / gene_center / gene?id=GRMZM2G471240, incorporated herein by reference). The unmutated GRMZM2G471240 is represented by SEQ ID NO: 1. GRMZM2G471240 containing the 4 bp insertion in the fourth exon is represented by SEQ ID NO: 3.
[0233] Most of the haploids identified were found using the taqman marker test. This marker test takes advantage of the difference in the pPLAIIα gene between RWK xNP2222. In our cross using RWK as the maternal parent and NP2222 as the paternal parent, the RWK parent is homozygous for the mtl allele, while NP2222 is homozygous for the MTL allele. The diploid offspring are MTL / mtl, and the haploid gynogenetic haploid offspring are mtl / 0. Therefore, when this test is completed, the taqman results show 1 copy of the mtl allele and 1 copy of the MTL allele in the diploid offspring, and 1 copy of mtl but no copies of MTL in the haploid offspring. When this type of cross is performed, the ears are harvested between 12–21 days after pollination, the embryos are extracted, and a small sample of the embryos is taken for taqman marker analysis. Alternatively, embryos are plated on solid medium and allowed to germinate in the dark, so that larger samples of extended shoots or roots can be taken for marker analysis between 2–10 days later. Some tissue is also saved for ploidy analysis. In the latter case, larger samples of haploids can be run on the CyFlow Space ploidy analyzer and confirmed as haploid after using molecular tests. In most cases, this results in a positive identification of haploids. In some rare cases, this has led to the subversion of false positive marker results and correction of the name to diploid.
[0234] Another way we test haploids is via dominant marker assays. In this case, the X26 male line is used. This line is homozygous for markers that work in a dominant manner. In such a cross, any line can be used as a female parent as long as it does not have a marker or any gene or allele that suppresses the marker phenotype. The X26 line is a non-inducer and is homozygous for MTL. Using such a line, the offspring are dissected and evaluated for the presence of markers between 12–21 days after pollination, or they are checked directly on the ear, or the dried grains are harvested and evaluated for the presence of markers. Diploid offspring show the marker phenotype because they have a single copy of the marker gene from the X26 father, but gynogenetic haploid offspring do not show the marker phenotype. The penetrance of the marker and the spontaneous haploid induction rate of X26 were tested in many control crosses. Using this system we screen haploids, and then test them on the ploidy analyzer to confirm that they are true haploids.
[0235] We developed a PCR test to specifically detect "wild-type" and "mutant" alleles for screening 19 inducers derived from Stock 6, including NP2222-haploid inducer (NP2222-HI) (a BC3 introgression of RWK into Syngenta's standard transformable inbred line NP2222). We also screened nine non-inducer control lines.
[0236] To develop a PCR test that distinguishes RWK / Stock6 from RWK-NIL haplotypes, two pairs of primers were designed: one to amplify the RWK / Stock6 frameshift allele and the other to amplify the B73 / RWK-NIL allele. These pairs worked as expected on RWK-NIL, RWK, and Stock6 DNA: RWK-NIL gDNA only amplified the RWK-NIL primer pair. RWK and Stock6 gDNA only amplified the RWK / Stock6 primer pair, which specifically detects the frameshift allele. The PCR products were sequenced and the sequence was identical to that from whole genome sequencing. The SNPs identified in the whole genome sequencing were confirmed in the PCR products. Below, Figure 2In the figure, the DNA used in each reaction is represented by capital letters. The primers are "nil.F1 / R1" and "rwk.F1 / R1". GRMZM2G471240_nil.F1: GTACGCCGTGCGCTAACA (SEQ ID NO:5). GRMZM2G471240_nil.R1: TCGTACCTCCCTGTCTCCAC (SEQ ID NO:6). GRMZM2G471240_rwk.F1: TACGCCGTGCGCTAACATA (SEQ ID NO:7). GRMZM2G471240_rwk.R1: GTACCTCGCTCCCTGTCTCC (SEQ ID NO:8).
[0237] The “rwk.F1 / R1” and “nil.F1 / R1” primer pairs were used to genotype a range of high, low, and non-inducers. We found that all 19 haploid inducer lines had the 4 bp insertion, including Stock6 (3% haploid induction rate [“HIR”]), RWK (a line derived from the University of Honheim stock, 10%–15% HIR), RWS, and Z22, among others. In contrast, the wild-type allele was found in all nine non-haploid inducer lines (average HIR of 0.1%). The data suggest that homozygosity for the frameshift allele correlates with induction capacity: 12 / 12 high and 7 / 7 low inducers amplified the frameshift assay but not the wild-type assay, whereas 9 / 9 non-inducers amplified the wild-type but not the frameshift assay. This suggests that the inducibility is associated with the GRMZM2G471240 mutation and that pPLAIIα is underlying qhir11 and is the major mutation responsible for haploid induction in these lines.
[0238]
[0239]
[0240] We also identified a number of single nucleotide polymorphisms ("SNPs") between the frameshift allele and RWK-NIL. For many of these SNPs, the STOCK6 and RWK sequences were consistent with other inbred species that we have sequenced, and therefore may represent natural variation. In fact, most of these SNPs do not change the amino acid sequence, and therefore may not contribute to the haploid induction phenotype. Two SNPs do result in amino acid changes (H107Y; K232N), and these are not highly conservative changes, so they may have a small contribution to the phenotype, but it is likely that they do not affect the phenotype because the frameshift results in a loss of function.
[0241] We renamed pPLAIIα "MATRILINEAL" (MTL; SEQ ID NO: 1) and the native 4 bp insertion allele "matrilineal" (mtl; SEQ ID NO: 3). According to the predicted protein sequence, the 4 bp insertion caused the open reading frame of the protein to shift at amino acid ("AA") 352 out of amino acid 401. The frameshift resulted in a premature stop codon.
[0242] After the discovery of the frameshift knockout mutation, we directly tested its effect on haploid induction by compensating the haploid inducer line with wild-type pPLAIIα transgenic. The heterologous compensation of NP2222-HI (10.2% HIR) with the wild-type copy of MATRILINEAL actually eliminated haploid induction and grain abortion. Compared with the control, HIR decreased by 50 times, from 10% to 0.23%. It also reduced the embryo abortion rate to 0.65%. The transgenic fusion of the wild-type MTL gene and GFP and the transgenic fusion of the mutant allele mtl and GFP were also used to prepare the full-length functional reporter gene strain, so as to visualize the subcellular localization of the wild-type MTL, and also to see whether the mutant version of the protein is correctly located or completely produced. These strains are also used as additional materials to test compensation. The homozygous haploid inducer material (NP2222-HI) for the MTL-GFP transgenic did not show the haploid inducer phenotype either. When being homozygous for MTL-GFP, the induction rate of NP2222-HI drops to 0.60%. In addition, the MTL-GFP transgenic also knocks down embryo abortion to 4.86%. Finally, we tested whether the mutant mtl allele fused to GFP compensates for the haploid induction phenotype, and it does not. Compared with the NP2222-HI homozygous for the mutant fusion transgenic mtl-GFP, haploid induction and embryo abortion rates are very similar in NP2222-HI. See Table 3. This represents the conclusive evidence that MATRILINEAL frameshift is responsible for haploid induction and is required for it. In order to apply this knowledge, we prove that mutation or regulation of pPLAIIα expression in wild-type strains leads to the generation of new haploid induction strains.
[0243] Table 3. Reproductive characteristics of haploid inducers, compensation and edited lines. This table shows haploid induction and grain abortion rates of inducer lines in the NP2222 background. First, the test cross number ("ear") is listed, and then the grain and embryo statistics are listed. Embryo abortion and haploid induction usually occur together on the same ear. This is why the embryo abortion rate is very high in the ears hybridized by the NP2222-HI male parent, with a haploid induction rate (HIR) of 10.17%. Two WT transgenics (including one without GFP and one fused to GFP) compensated for the haploid induction phenotype. At the same time, the mutant mtl fused to GFP was not compensated.
[0244]
[0245] Using transcription activator-like effector nucleases (TALENs), several mtl-like alleles were generated in the inbred NP2222 by introducing small deletions into MTL near the 4 bp insertion site in mtl (Boch, J. et al., Breaking the code of DNA binding specificity of TAL-type III effectors, SCIENCE 326: 1509–1512 (2009), incorporated herein by reference). Several mutant events were self-pollinated, and T1 plants lacking the TALEN T-DNA insertion but homozygous for the small deletion in MTL were outcrossed with NP2222. MTL (hereinafter referred to as MTL TAL-FS ) exhibited HIRs of 4.0%–12.5% (average 6.65%) (Table 4). The ploidy status of 118 / 127 putative haploids was confirmed by flow cytometry, and phenotypic evaluation indicated that these plants were haploid. These results demonstrate that the frameshift in MTL is sufficient to induce a high rate of haploid induction. Other contributors to the phenotype have been located, including the neighboring qhir12 (see Liu, 2016), which may explain the MTL TAL-FS It is reasonable to infer that the seed setting rate, HIR rate and grain abortion rate are set by mtl through paternal and maternal genotype-specific interactions.
[0246]
[0247] Haploid seed formation in maize is a postzygotic feature caused by defective male gametophytes. This fact is reflected in the MTL expression data. Public RNA-seq profiles show that wild-type MTL transcripts are specific to anthers during flowering (see Sekhon, RS et al. Genome-wide atlas of transcription during maize development [whole genome transcription map during maize development], PLANT JOURNAL [Plant Journal], 66, 553-563 (2011), incorporated herein by reference), consistent with the developmental profile found only in anthers before dehiscence (see Zhai, J. et al. Spatiotemporallydynamic, cell-type–dependent premeiotic and meiotic phasiRNAs in maize anthers [with spatiotemporally dynamic, cell-type-dependent premeiotic and meiotic phasiRNAs in maize anthers], PNAS [Proceedings of the National Academy of Sciences of the United States of America] 112, 3146–3151 (2015), incorporated herein by reference). We found that wild-type pollen had 18-fold more MTL transcripts than post-anthesis anthers, indicating that the gene is male gametophyte specific ( Figure 3 ). Attempts to knock down MTL by RNAi resulted in only MTL RNAi The haploid formation rate of NP2222-HI was increased (Table 5). There are two annotated MTL splice variants, reflecting the alternative splice site 81 nucleotides before the 3' end of exon 2. Compared with NP2222, Mtl was found in NP2222-HI but not in MTL. TAL-FS Pollen increased ( Figure 4 ), whereas the abundance of the two annotated splice variants was consistent.
[0248] Table 5. RNAi construct 22503 (SEQ ID NO: 32) knocks down Mtl resulting in haploid induction.
[0249]
[0250] The frameshift in mtl occurs at amino acid 380, resulting in 20 altered amino acids, followed by a premature stop codon that truncates the protein by 29 amino acids ( Figure 5a). Wild-type MTL protein was found in the LS-MS spectra of RWK-NIL and NP2222 pollen, but below the detection limit in three of the three RWK and three of the three NP2222-HI samples (Table 6). This indicates that even though the mutant mtl transcript was produced in the pollen, the protein was not detected, confirming that this is a loss-of-function mutation. Both mutant and wild-type recombinant MTL proteins exhibited in vitro phospholipase activity in a pPLAIIα-like fluorescent liposome cleavage assay ( Figure 5 b). This indicates that the functional annotation of the MTL gene (i.e., that it encodes a phospholipase protein) is correct.
[0251] Table 6. Proteins that are turned off and on in NP2222 and NP2222-HI pollen samples, including MTLs found in NP2222 pollen but not in NP2222-HI pollen.
[0252]
[0253] *ND, not detected
[0254] II. Pollen germination and localization experiments
[0255] Full-length functional reporter gene lines were used to characterize MTL localization. No signal was found in the pollen of NP2222 or NP2222+mtl-GFP / mtl-GFP. In contrast, NP2222+MTL-GFP / MTL-GFP pollen showed strong signals in the cytoplasm of two sperm cells. This signal was found in the sticky gamete cytoplasm in the germinating pollen tube. The NP2222 embryo sac fixed with MTL-GFP pollen 18 hours after pollination had a signal consistent with the SC delivered during fertilization in the region of the degenerated synergid. This indicates that MTL is part of the male reproductive unit deposited in the embryo sac after pollen tube rupture. MTL-GFP but not mtl-GFP eliminated the haploid induction in NP2222-HI (Table 3). In general, these data indicate that MTL is a phospholipase specific to the SC cytoplasm, and the frameshift in mtl compromises the MTL localization or stability in the haploid inducer pollen.
[0256] Identification of MTL as an induced gene in haploid induction in maize allows for the dissection of pleiotropic phenotypes historically associated with the trait. Phospholipase mutations are associated with delayed pollen germination and tube growth (see Kim, HJ et al. Endoplasmic reticulum-and golgi-localized phospholipase A2 plays critical roles in Arabidopsis pollen development and germination, PLANT C ELL Plant Cell 23, 94-110 (2011)), but these are in RWK, Stock 6 and MTL TAL-FS The strain is normal ( Figure 6 A. Figure 6 B) Using NP2222-HI and MTL TAL-FS Pollen-pollinated ears showed approximately 10%-25% fertilization failure, and pollen competition assays showed that RWK was prone to segregation deviation (SD) ( Figure 6 C), consistent with previous reports (see Xu, X. et al. Gametophytic and zygotic selection leads to segregation distortion through in vivo induction of amaternal haploid in maize, J. EXP. BOT. 64, 1083-1096 (2013)). Crosses with hemizygous NP2222-HI+MTL / 0 pollen produced a proportional bias toward MTL+ progeny ( Figure 6 D), indicating that the induced SD is attributed to mt1. The persistent byproduct of haploid induction associated with endosperm proliferation failure is embryo abortion in both native and MTL TAL-FSInducers occurred at similar rates (Table 4). Collectively, these data implicate mtl in each of the reproductive defects associated with haploid induction. Two mechanisms commonly proposed to explain haploid formation are single fertilization and postzygotic genome elimination (see Sarkar, K. R. and Coe, E. H., A genetic analysis of the origin of maternal haploids in maize, GENETICS 54, 453-464 (1966); Zhang, Z. et al., Chromosome elimination and in vivo haploid production induced by Stock 6-derived inducer line in maize (Zea mays L.), PLANT CELL REP. 27, 1851-1860 (2008); and Barret, P., Brinkmann, M. and Beckert, M., A major locus expressed in the malegametophyte with incomplete penetrance is responsible for in situ gynogenesis in maize [A major locus expressed in the male gametophyte with incomplete penetrance is responsible for in situ gynogenesis in maize] THEOR. APPL. GENET [Theoretical and applied genetics] 117, 581–594 (2008)). In the former, haploidy results from fertilization of the central cell rather than the egg, which then develops via parthenogenesis. In the latter, double fertilization precedes male chromosome elimination. Elucidation of the precise mechanism will require further investigation in MTL. TAL-FS Careful embryological studies after pollination, along with quantitative data tracking the persistence of rare male DNA in maize haploids.
[0257] Recently, haploid induction was engineered in Arabidopsis via manipulation of CENTROMERIC HISTONE 3, which caused uniparental genome elimination through postzygotic centromere imbalance between hybrid genomes. Attempts to replicate this in maize were successful (see Ravi, M. and Chan, S. W. L. Haploid plants produced by centromere-mediated genome elimination, NATURE 464, 615-618 (2010)), but this paper is the first example of a haploid inducer system triggered by a cytoplasmic protein that does not bind to chromatin. Therefore, this work highlights the importance of non-nuclear sperm components in reproductive success and faithful genome transmission. The conservation of MTL in grasses (especially in rice where the closest homolog is pollen-specific and is also found in sperm) (see Figure 7 ), suggesting that these findings will lead to the development of novel intraspecific haploid inducer lines in important crop plants.
[0258] III. Chemical sprays to induce de novo HI
[0259] Following the discovery that MTL phospholipases (and specifically, mtl loss-of-function frameshift mutations) trigger haploid induction, we tested whether phospholipase inhibitors, fatty acids, or other lipid compounds could serve as chemical haploid inducers.
[0260] We have successfully achieved de novo haploid induction by applying various chemicals to flowers, silks, fringe, tassels and pollen. These chemicals all belong to the category of lipids or phospholipase inhibitors. Table 7 has summarized those chemicals and the haploid induction rate caused by their application. Also in Table 7 are formulation information and application information. From this table, it can be clearly seen that when applied to silk (which is the stigma tissue specific to corn plants), pollen, tassels (which comprise the male flowers containing pollen before pollen falls) and fringe before pollination, during pollination or after pollination, multiple lipid compounds induced haploid from the beginning. Such compounds include mixed oils, fatty acids, fatty acid esters, phospholipids and phospholipase inhibitors.
[0261] We tested many phospholipase inhibitors, including spongolipid, a phospholipase inhibitor without any fatty acid chains. This chemical was able to induce haploid formation de novo. With this result, we started testing more compounds. We found that the most active compound for de novo induction was methyl alpha-linolenoyl fluorophosphonate (MALFP), a potent phospholipase inhibitor and inhibitors of other lipid-modifying enzymes. This compound contains three linolenic acid fatty acid chains (18 carbon atoms and three triple bonds) and a hydroxymethyl (methyol) group and a fluorine atom at the head group position. Another highly active de novo haploid inducer compound was methyl arachidonoyl fluorophosphonate (MAFP), another phospholipase inhibitor with a slightly different fatty acid chain structure (20 carbons and four double bonds). Without wishing to be bound by theory, MALFP and MAFP inhibit phospholipases by being located in the fatty acid chain binding pocket and in some cases by catalyzing the irreversible phosphorylation of a serine amino acid in the active site (see Lio YC, Reynolds LJ, Balsinde J. and Dennis E.A. Irreversible inhibition of Ca(2+)-independent phospholipase A2 by methylarachidonyl fluorophosphonate. BIOCHIM BIOPHYS ACTA 1302:55-60 (1996). Some fatty acids (e.g., linoleic acid and linolenic acid) can also inhibit phospholipases non-competitively by being located in the fatty acid chain binding pocket without covalently modifying the active site, but the inhibition is less potent. Ballou, LR and Cheung, WY Inhibition of human platelet phospholipase A2 activity by unsaturated fatty acids PROC NATL ACAD SCI 82(2):371-375 (1985).These references may help explain the reasons for our findings: de novo haploid induction is triggered not only by strong inhibitors of phospholipases (like MALFP and MAFP), but also by fatty acid esters, including: arachidonic acid methyl ester (AAME) with 20 carbons and four double bonds (polyunsaturated 20-carbon fatty acid esters), and linoleic acid (LLE) with 18 carbons and two double bonds (18:2), and linolenic acid (LNA) with 18 carbons and three double bonds (18:3), and oleic acid ethyl ester (OAEE), and arachidonic acid (which has 20 carbons and four double bonds). It is also believed that these unsaturated fatty acid chains, whether in their free fatty acid form, their ester form (which is synthesized in the laboratory and can penetrate tissues), or in some other form, can act as inhibitors of phospholipases. Although it is not generally believed that the ester form of these compounds can inhibit phospholipases (see Ballou, supra), we have found that such fatty acid methyl esters and fatty acid ethyl esters can indeed lead to de novo haploid function. See Table 7. It is noteworthy that saturated fatty acids and derivatives were tested, including stearic acid and ethyl palmitate. The prior art points out that molecules containing saturated fatty acid side chains will not or will not be able to competitively inhibit phospholipases by residing in their active sites. See Ballou, supra. It is believed that such compounds lack the ability to inhibit phospholipases. However, surprisingly, we can use molecules containing saturated fatty acid side chains to induce the formation of haploids from scratch. For example, ethyl palmitate (PAEE) induces haploids. See Table 7.
[0262] We also decided to test whether certain oils and phospholipids could trigger de novo haploid induction, including common plant oils. We found that one highly active de novo haploid inducer lipid mixture was corn oil (a natural plant extract that can be purchased from the grocery store). Another highly active lipid mixture was flaxseed oil, which can be purchased from the hardware store. Canola oil, vegetable oil, peanut oil, sesame oil, or any other oil also works well when applied in the right way. Another highly active compound was 1,2-distearoyl-sn-glycero-phosphatidylcholine (DSPC) (also known as 18:0 18:0PC) (a phospholipid with a phosphatidylcholine head group and two 18-carbon saturated fatty acid chains). This common phospholipid is present in many biological materials as it is one of the core and most abundant components of the phospholipid bilayer, which makes up the cell membranes of all organisms on Earth. Another haploid inducing compound is phosphatidylethanolamine with one stearoyl and one oleoyl chain (also known as 1-stearoyl-2-oleoyl-sn-phosphatidylethanolamine), another common phospholipid. Other phospholipids and lysophospholipids and other triacylglycerols, diacylglycerols, lysophospholipids, triterpenoids or glycerolipids will serve as de novo haploid inducers. These oils and phospholipids are usually known to not inhibit phospholipases, but they may be raw materials that produce phospholipases active byproducts, including the unique fatty acid that inhibits phospholipases. Therefore, the fact that these compounds serve as de novo haploid inducer chemicals shows that these oils and phospholipids may indirectly inhibit phospholipases, or they may cause the lipid or membrane composition of pollen to be unbalanced or change, thereby causing haploid induction. Either way, it is clear from this work that, except non-lipid phospholipases inhibitors, a large amount of lipid-containing compounds can serve as chemical inducers of haploid seeds when applied to flowers.
[0263] We also tested whether the buffers we used to apply the compounds to flowers could independently induce haploids. These buffers variably included certain surfactant blends and / or salts and / or DMSO (dimethyl sulfoxide) and / or other relevant additives. These buffers were unable to induce haploids, as can be seen in rows 121–123 of Table 7. Also, as can be seen from row 1, de novo haploid induction in maize without any added compounds is very rare. Two haploids were found in 3,073 progeny tested (Kelliher et al. Maternal haploids are preferentially induced by CENH3-tailswap transgenic complementation in maize, FRONTIERS IN PLANTSCIENCE 7:414 (2016)). Thus, the control induction rate was found to be approximately 0.065%, which falls within the background of reported gynogenetic haploid induction (0.05%-0.1%) (Chang, M.-T. and Coe, E. "Doubledhaploids," in Molecular Genetic Approaches to Maize Improvement, eds. A. L. Kriz and B. A. Larkins (Heidelberg: Springer), 127-142).
[0264] The mode of application of these different lipids and lipase inhibitor compounds can be very varied and still produce haploids. One such mode of application is to dissolve the compound in a saline solvent added with 1% DMSO. Another such solvent is a surfactant blend (Table 8). As is apparent from Table 7, the application tissue can also vary, wherein application to both pollen and filaments during pollination and application to male tassels a few hours or days before pollination can cause haploid formation. In addition, compounds of various concentrations can induce haploids, from 20 μM to 100mM or from 0.2mg / mL until 50mg / mL. In fact, as can be seen from Table 7, haploids can be induced in a much wider range than this.
[0265] In both cases, we have also developed novel surfactant blends to help specific classes of lipids to be emulsified and form microemulsions (lipid droplet sizes less than a certain size - at least less than 10 microns in diameter and in many cases less than 1 micron in diameter aqueous-organic blends). See Table 8 for the composition of the two surfactant blends. Blend "91" is ideally used with fatty acids at a concentration of 6.5 parts of surfactant blend to 1 part of fatty acid. However, a variety of related concentrations and related surfactant blends can also work. Surfactant blend "92" is ideally used with fatty acid esters and oils (in pure form or as a triglyceride mixture). Ideally, this is mixed in a ratio of 10 parts of surfactant blend to 1 part of ester or oil. Any of these blends or related blends of compounds may be suitable for appropriate dissolution or microemulsion construction with related lipid molecule classes other than fatty acids, esters and oils. These can include phospholipids, diacylglycerols, lysophospholipids, triterpenoid esters or glycerolipids.
[0266] These surfactant blends are typically mixed with the active ingredient and then mixed with an aqueous buffer at a certain percentage to prepare an emulsion and ideally a microemulsion. When preparing an emulsion, the percentage of surfactant blend + active ingredient in the aqueous buffer can be anywhere from 0.01%-50%. The aqueous buffer can be composed of any number of substances. We used 1x PBS + 1% DML and PBS + 50% DML, but other formulations work just as well. "PBS" stands for phosphate buffered saline; "DML" stands for dimethyl lactamide.
[0267] Use of these buffers alone did not result in de novo haploid induction, as can be seen in Table 7, rows 121–123.
[0268] The application mode of the compound can adopt any number of forms, including flower dipping, flower injection, microinjection, pollen soaking, pollen mist, pollen spray, flower mist, flower spray, silk soaking, silk spray etc. Before pollination, during pollination or after pollination, we most often use male tassel, pollen and silk spray. When male tassel was sprayed two days before pollination, we realized de novo haploid formation with DSPC and linolenic acid. When male tassel was sprayed a few minutes before pollen collection and subsequent pollination, we also used DSPC to realize de novo haploid formation. Similarly, when just before pollination or during pollination, pollen was sprayed, and also before pollination, during pollination or after pollination (including up to two days before pollination and up to six hours after pollination) silk was sprayed, we used DSPC to realize de novo haploid formation.
[0269] We also demonstrated de novo haploid formation when using different applicators, including cheap plastic spray bottles that one can buy at convenience stores; nebulizers, which are medical devices used to deliver drugs orally in the form of very small water droplets. While spray bottles typically produce droplet sizes of 50-150 microns in diameter, nebulizers are able to produce droplet sizes less than 10 microns. This is beneficial for application to pollen, because pollen sizes range from 20-200 microns in diameter in most plants (about 70 microns in corn; about 50 microns in rice), and if one of the droplets from a typical spray bottle hits a pollen grain, the droplet will be larger than the pollen grain. Pollen is very sensitive to moisture and osmotic shock. If a pollen grain comes into contact with a droplet that is too large, the pollen grain cannot germinate a successful, growing pollen tube. The same may be true if the pollen grains land on a stigma or silk that is too wet - for example, if the silk or stigma received too much lipid application (be it a microemulsion, or simply lipid droplets or micelles formed in an aqueous solution). If we apply more than 3 mL of lipid spray to the pollen or silk via a spray bottle or atomizer, we usually get very low seed set.
[0270] Therefore, the mode of application is critical, and in particular it is of utmost importance to generally try to apply as little spray volume as possible to the pollen or stigma or filament or flower, and the best way to distribute as little volume of active ingredient (especially lipid) as possible is to prepare a microemulsion of the lipid in an aqueous buffer, wherein the lipid droplet size is at the submicron level, and then distribute the microemulsion using a nebulizer or similar device that is capable of droplet sizes in the 1-2 micron range. This results in the delivery of millions of droplets of active ingredient in the form of a "vapor" to the relevant tissue, wherein the droplet size is >100,000 times smaller in volume than the pollen grain itself (if the droplet is 1 micron, and the pollen grain is 50 microns, then the diameter of the droplet is 50 times smaller than the pollen grain. And 50 3 = 125,000, so the volume of the droplet is > 105,000 times smaller than the pollen grain. For microemulsions, the diameter of the lipid droplet size can range from about 20–1000 nm, so depending on the concentration of the surfactant blend plus the active ingredient in the aqueous solution, one can deliver one or more lipid packets per droplet to each pollen grain or filament. In addition, given that some lipid-type molecules or phospholipase inhibitors can be dissolved in aqueous solutions rather than delivered as microemulsions, we found that various concentrations of the compound can induce haploidy, from 20 μg / mL up to 50 mg / mL. It is possible that higher concentrations will induce haploidy de novo.
[0271]
[0272]
[0273]
[0274]
[0275]
[0276]
[0277]
[0278] Table 8. Formulations of Formulation 91 ("F91") and Formulation 92 ("F92"), which aid in the emulsification of active ingredients such as fatty acids, oils, esters, and phospholipids in very small lipid droplets. Formulation 91 is a surfactant blend that is optimally mixed with fatty acids at 1 part fatty acid to 6 and a half parts Formulation 91. The mixture is meant to produce an emulsion at a concentration of 0.001%-50% with an aqueous buffer. Formulation 92 is also a surfactant blend that can be optimally mixed with an ester or oil at 1 part active ingredient to 10 parts Formulation 92 and then emulsified in an aqueous buffer at a concentration of 0.001%-50%.
[0279]
[0280] IV. Improving HIR and restoring seed set by applying lipid compounds
[0281] The molecular profile analysis (including metabolomics and lipidomics analysis) of haploid inducer and non-inducer pollen (comparatively) shows that haploid inducer pollen is particularly insufficient in certain types of lipid categories and excessive in other categories. This deficiency is particularly significant in the 18 carbon chain categories of lipid molecules, although it is also visible in the 20 carbon chain categories. Insufficient is particularly significant in the 18 carbon chain lipids (so-called oleic acid ester and linoleic acid ester) with one and two double bonds, and excessive is especially found in the 18 carbon chain lipids (so-called linolenic acid ester) with three double bonds. About the lipid types that change in haploid inducer pollen, it is very wide, and includes triglyceride, diacylglyceride, free fatty acid, lysophospholipid and phospholipid. The change of lipid content in haploid inducer pollen across different levels of fatty acid saturation is also variable. After seeing this data, we decided to apply lipid compounds to flowers during pollination with haploid inducer pollen to see whether simple addition of certain types of lipids can affect haploid formation rate or grain count. We were particularly interested in administering compounds that contained some 18 or 20 carbon saturated fatty acid chains in their molecular structure, among those that appear to be in lower abundance in haploid inducer pollen (such as oleic and linoleic acids).
[0282] As shown in Tables 10-13, lipid application may also result in increased haploid formation rate, seed set rate, and decreased kernel abortion frequency. Table 10 shows nine separate control experiments using the compound methyl α-linolenoyl fluorophosphonate (MALFP). Each experiment involved two ears that were crossed on the same day, at almost exactly the same time (within 5 minutes of each other) by the same haploid inducer male plant from the exact same pollen population collected from the same male parent. The two ears received either a control buffer application, or buffer plus active ingredient. Both the test male and test female plants were grown next to each other in the same greenhouse under the same conditions. On average, and compared to the control application of buffer without MALFP, when MALFP was applied, the haploid induction rate increased by 3.6%, the kernel number increased by nearly 42 / ear, and the total number of haploids recovered per ear increased by 11.8 haploids / ear, and the frequency of embryo abortion decreased by 1.1% (Table 9). All of these represent improvements in the haploid induction production protocol. The improvement was particularly evident when Formulation 91 was used as a surfactant blend to solubilize MALFP. A possible mechanism by which these inhibitors have an additive effect with mtl leading to higher induction rates is that they disrupt other phospholipases or lipid-modifying proteins.
[0283] The same type of data was collected for the fatty acid ethyl ester LLAEE, which resulted in a 2.4% increase in haploid induction, over 43 more kernels formed per ear, over 8 more haploids per ear, and a 3.7% decrease in embryo abortion frequency. Although many of these treatments involved different amounts of active ingredients, in most of these experiments, LLAEE resulted in an increase in these haploid formation and seed set statistics. See Table 10.
[0284] The same type of data (table 11) of the fatty acid linoleic acid (LLA) were collected, resulting in an increase in haploid induction rate of 1.5%, an increase in 41 surviving grains per ear and an increase in 7.6 haploids per ear, and a reduction in embryo abortion rate of 2.9%. This is the result of 22 independent experiments, each of which consists of an ear pollinated by a control buffer and an ear pollinated by a buffer plus active ingredient (LLE). Interestingly, the abundance of 18:2 in the haploid inducer pollen decreases (as shown by lipidomics data). It is not desirable to be bound by theory, but it is reasonable to speculate that this may cause or contribute to fertilization problems and embryo abortion. When we add these back to LLA and LLAEE via spraying, these molecules may inhibit phospholipase to cause higher HIR, and compensate for 18:2 to cause more grains.
[0285] Finally, similar data were collected for MAFP, and similar results were seen, including a 1.9% increase in haploid induction rate, a 6.6 increase in the number of haploids recovered per ear, a 28 increase in total kernel number, and a 2.2% decrease in embryo abortion (Table 12). These compounds, as well as other lipids, can be used to increase the frequency of haploid embryo formation in haploid induction nurseries, and can also be used to increase seed setting in the context of self-pollinating haploid induction lines in order to increase more elite seed for those lines.
[0286] Table 9. Effect of MALFP on HIR, seed set, kernel abortion and total haploids recovered.
[0287]
[0288] Table 10. Effect of LLAEE on HIR, seed set, kernel abortion and total haploids recovered.
[0289]
[0290]
[0291] Table 11. Effect of LLA on HIR, seed set, kernel abortion and total haploids recovered.
[0292] Comparison of linoleic acid (LLA) with control
[0293]
[0294]
[0295] Table 12. Effect of MAFP on HIR, seed set, kernel abortion and total haploids recovered.
[0296] Comparison of MAFP with controls
[0297]
[0298]
[0299] V. Mutagenesis / knockout of PLA
[0300] Efforts were made to change the haploid induction rate or reduce the embryo abortion rate during the haploid induction hybridization. We produced or obtained several mutant strains by several methods, including GM RNAi strains, TILLING strains, CRISPR strains and TALEN strains. First, we sought that the directed mutagenesis of pPLAIIα was evidence of a feasible strategy for producing new haploid inducer strains. Therefore, for the same sequence containing frameshifts in mutant haploid inducer alleles, we tested both CRISPR / CAS9 and TALEN corn directed mutation strategies. This resulted in the production of strains with novel mutations, and we tested its haploid induction.
[0301] There are three key components in the CRISPR process. See U.S. Patent No. 8,697,359B1, which is incorporated herein by reference in its entirety. The first key component is the target sequence. The second is Cas9, which is an endonuclease. The third key component is a guide RNA ("gRNA"), which is complementary to the target sequence and is responsible for recruiting Cas9 to the desired position. The target sequence is 18 to 20 bp in length and should optimally be located just 5' of the protospacer sequence adjacent to the motif ("PAM") in the plant genome. For Cas9 from Streptococcus pyogenes, the PAM sequence should be 5'-NGG-3'. Transcription of gRNA can be driven by Pol III promoter U3 (RNA starts at A) or U6 (RNA starts at G). gRNA should carry the target sequence at the 5' end just after A (U3) or G (U6). Cas9 will produce a double-strand break ("DSB") at the target sequence 3 base pairs 5' of the PAM sequence. The amino acid sequence of Cas9 is identical to that of Cas9 from Streptococcus pyogenes strain SF370, with two amino acid changes (L1164V and I1179V) in the PI domain (1099–1368) in NUC leaves. Cas9 activity has been demonstrated in transformation experiments in maize with a mutation frequency of approximately 90% of the tested target sequences. In general, it is wise to identify multiple candidate PAM and target sequences in the target region and then look for the best one by observing which sequences are unique in the genome of the target. The target plant is maize, rice, or any monocot.
[0302] According to this strategy, the CRISPR target sequence overlapping with the existing frameshift mutation is identified. The precise cutting position is only two base pairs away from the insertion point in the frameshift. The construct containing both Cas9 and gRNA is transformed into corn plants. Generally, double allelic or homozygous mutant plants can be recovered from the multiple events produced, but heterozygous mutant plants are also useful. The heterozygous plants are self-pollinated, and then T1 seeds are grown, the homozygosity of the mutation is screened, and outcrossing is performed. Simply make the homozygous or double allelic mutant T0 transformant self-pollinated and outcrossed with unconverted NP2222. All outcrossed embryos are separated for ploidy analysis to find haploids.
[0303] Three different targeted mutagenesis constructs were generated: CRISPR / CAS9 I, CRISPR / CAS9 II, and TALEN. The differences between CRISPR / CAS9 I and CRISPR / CAS9 II are minimal. The target site locus for all three constructs is the same region where frameshifts are found in haploid inducer lines. For the CRISPR construct, the guide RNA sequence begins at nucleotide +1560: -GTCAACGTGGAGAC AGG G- (i.e., SEQ ID NO: 20). The –AGG–PAM site of SEQ ID NO: 20 is underlined and italicized. The insertion of the four base pairs in the haploid inducer line was at this exact site, nucleotide +1576. After transformation, several different CRISPR I events (including the expression construct found in SEQ ID NO: 34), CRISPR II events (including the expression construct found in SEQ ID NO: 36), and TALEN events (including the expression construct found in SEQ ID NO: 35) were selected, grown to maturity, and viable seeds were produced. In the T0 generation, we performed PCR at the target site and sequenced the PCR products after subcloning. We identified many unique mutations in those events (and many events were mosaic or had multiple alleles).
[0304] Many plants were mosaic, as evidenced by the appearance of multiple different sequences in the T1 generation. After T0 self-pollination, T1 plants segregated 1:2:1 for the targeted mutagenesis construct, and many had novel mutations at the target locus in either a biallelic or homozygous state. We screened seedlings at the DNA level using TAQMAN markers, identified biallelic genes lacking the Cas9 or TALEN transgene, and performed PCR sequencing to generate PCR product reads from base pairs +1494 to +1691 in the GRMZM2G471240 gene sequence. We then tested the haploid induction ability of the homozygous mutants. See SEQ ID NOs: 9–19 and 42–44 for the sequences of the new T1 plants at the mtl gene.
[0305] Measure the HIR of the putative new strain. See Table 4 above. This HIR data comes from a hybridization in which the male parent is a putative haploid inducer strain and the female parent is our standard inbred conversion strain NP2222. The putative haploid inducer strain is produced using TALEN-mediated or CRISPR / CAS9-mediated directed mutations of the pPLAIIa locus. Among those shown here, there are eleven different putative inducer plants, which contain eight different events from three different transformation constructs. Event 39A is a TALEN event. Events 18A and 27A are CRISPR events. The latter is a chimera as a T0 plant, and after its self-pollination, multiple mutations were found in the T1 population, including "biallelic" plants (by so-called biallelic, we mean that when we sequenced the region of the mutated pPLAIIα, we found two different novel alleles-making it clear that the two wild-type copies of the gene have mutated, but they mutated in different ways, so there are two novel alleles). So, each of these 11 individual plants had a different combination of mutations in pPLAIIα. What they all had in common was that none of the 11 plants had a wild-type copy of pPLAIIα. So, these were all "homozygous mutants" of the pPLAIIα gene. The mutations were all frameshifts in exon 4, mimicking the original mutations in the natural haploid inducer line. Using these five plants as male parents, we crossed on one or a few female ears, producing thousands of embryos. We dissected those offspring and analyzed their ploidy, and found that each of the offspring groups had at least 3.98% haploid and at most 12.5% haploid. This suggests that generating mutations in pPLAIIa will lead to haploid induction. We think that other types of mutations besides frameshifts will also lead to haploid induction. Those mutations can be anywhere in the gene, and they can be point mutations or insertions or deletions or other types of mutations.
[0306] RNAi was also used to generate haploid inducer lines. For RNAi, two hairpin constructs were made; one targeted to the boundary between exons 1 and 2, and the other targeted to exon 4 ( Figure 8 and Fig. 9 ). The construct was transformed into the wild type, and the T0 plants were selfed. T1 seeds from 3 events of each construct were cultivated, screened for homozygosity of the transgene, and outcrossed on several ears as test objects for haploid induction. After examining more than 1500 grains from these outcrosses, we found that both events induced haploids at a rate of approximately 1% to 2%. The highest haploid induction rate obtained on a single ear was 4.3%. The ear had about 300 grains, so we can conclude that the embryo abortion rate was also lower than that of a typical high inducer line. This work demonstrates that the RNAi+GM strategy can be used to generate new haploid inducer lines in other typical wild-type lines by altering the expression of pPLAIIα.
[0307] The TILLING mutagenesis method is also used to generate and identify phospholipase mutations and corn of the present invention. Publications describing TILLING are available for crop plants such as rice (Till et al., BMC Plant Biology 7: 19 (2007)), tomato (Rigola et al., PLOS ONE [Public Library of Science Comprehensive] March 13, 2009), and corn (Till et al., BMC Plant Biol. [BMC Plant Biology] July 28, 2004; 4: 12 (2004)), all of which are incorporated herein by reference. In the basic TILLING methodology, plant material (such as seeds) is subjected to chemical mutagenesis, which produces a series of mutations in the genome of the seed cells. The mutagenized seeds are grown into M1 adult plants and self-pollinated. DNA samples from the resulting M2 plants are merged, and then the mutations in the gene of interest are screened. Once a mutation is identified in a gene of interest, seeds from M2 plants carrying the mutation are grown into M3 adult plants and screened for phenotypic characteristics associated with the gene of interest.
[0308] Any corn cultivar having at least one phospholipase gene with substantial homology to SEQ ID NO:1 can be used according to the present invention. As used herein, "substantial homology" means that the DNA sequence of the gene is sufficiently similar to SEQ ID NO:1 at the nucleotide level to encode a protein equivalent to SEQ ID NO:1, thereby allowing for allelic differences between cultivars. According to one aspect of an exemplary embodiment of the present invention, "substantial homology" may exist when the homology between the phospholipase gene and SEQ ID NO:1 is as low as about 85%, provided that the homology in the conserved regions of the gene is higher (e.g., at least about 90%). Preferably, the percent identity in the coding region is 85%-90%, more preferably 90%-95%, and optimally more than 95%. Those skilled in the art may prefer corn cultivars with commercial popularity or cultivars of corn with specific desired characteristics to produce phospholipase mutations. Alternatively, those skilled in the art may prefer corn cultivars with a few polymorphisms, such as inbred cultivars, to facilitate the screening of mutations within the phospholipase locus.
[0309] According to an aspect of an exemplary embodiment of the present invention, seeds from rice and corn are mutagenized and then grown into M1 plants. Then the M1 plant is allowed to self-pollinate, and the seeds from the M1 plant are grown into M2 plants, and then the mutations in the phospholipase loci of the M2 plants are screened. Although the mutations of the M1 plant can be screened, the advantage of screening the M2 plant is that all somatic mutations correspond to germline mutations. Those skilled in the art will recognize that various corn plant materials (including but not limited to seeds, pollen, plant tissues or plant cells) can be mutagenized to produce corn with phospholipase mutations of the present invention. However, the type of mutagenized plant material may affect when to screen the mutation of plant DNA. For example, when pollen is mutagenized before pollination of a non-mutated plant, the seeds produced by the pollination are grown into M1 plants. Each cell of the M1 plant will contain the mutations produced in the pollen, so the phospholipase mutations of these M1 plants can be screened then, rather than waiting for the M2 generation.
[0310] Mutagens (eg, chemical mutagens or radiation) that produce primarily point mutations and short deletions, insertions, transversions, and or transitions (about 1 to about 5 nucleotides) can be used to generate mutations of the invention. Mutagens consistent with the methods of the present invention include, but are not limited to, ethyl methanesulfonate (EMS), methyl methanesulfonate (MMS), N-ethyl-N-nitrosourea (ENU), triethylmelamine (TEM), N-methyl-N-nitrosourea (MNU), procarbazine, chlorambucil, cyclophosphamide, diethyl sulfate, acrylamide monomer, melphalan, nitrogen mustard, vincristine, dimethylnitrosamine, N-methyl-N'-nitro-nitrosoguanidine (MNNG), nitrosoguanidine, 2-aminopurine, 7,12-dimethylbenzanthracene (DMBA), ethylene oxide, hexamethylphosphoramide, busulfan, diepoxyalkanes (diepoxyoctane (DEO), diepoxybutane (BEB) and the like), 2-methoxy-6-chloro-9[3-(ethyl-2-chloro-ethyl)aminopropylamino]acridine dihydrochloride (ICR-170), and formaldehyde. According to various embodiments of the present invention, spontaneous mutations in the nucleolar organizer region ("NOR") that may not be directly caused by the mutagen may also be identified.
[0311] Any suitable plant DNA preparation method now known or later devised can be used to prepare corn plant DNA for phospholipase mutation screening. See, e.g., Chen and Ronald, Plant Molecular Biology Reporter 17:53-57, 1999; Stewart and Via, Bio Techniques 14:748-749, 1993. In addition, several commercial kits are available, including kits from Qiagen (Valencia, California) and Qbiogene (Carlsbad, California).
[0312] According to an aspect of an exemplary embodiment of the present invention, preparation is from the DNA sample of individual corn plant, and then merges in order to accelerate the sudden change in the phospholipid hydrolase of the whole plant population from the plant tissue source of mutagenesis.The size of merging group may depend on the sensitivity of employed screening method.According to an aspect of an exemplary embodiment of the present invention, merge the group of four or more individual corn plants.
[0313] According to another aspect of an exemplary embodiment, after merging DNA samples, the library is subjected to a phospholipase sequence-specific amplification technique, such as polymerase chain reaction (PCR). For a general overview of PCR, see PCR Protocols: A Guide to Methods and Applications (Innis, Gelfand, Sninsky, J. and White, ed.), Academic Press, San Diego, 1990, which is incorporated herein by reference. Any primer specific to the phospholipase locus or to the sequence next to the phospholipase locus can be used to amplify the phospholipase sequence in the merged DNA sample. Preferably, primers are designed to amplify the phospholipase locus region where useful mutations are most likely to occur. Most preferably, primers are designed to detect mutations in the phospholipase gene coding region. In addition, it is preferred that primers avoid known polymorphic sites so as to be easy to screen for point mutations. In order to facilitate detection of PCR products on gels, any conventional or later designed labeling method can be used to label PCR primers.
[0314] According to one aspect of an exemplary embodiment of the present invention, any method for identifying the nucleotide differences between the wild-type and mutant sequences can be used to screen the phospholipase mutations of the PCR amplification products. These can include, but are not limited to, sequencing, denaturing high pressure liquid chromatography (dHPLC), constant denaturant capillary electrophoresis (CDCE), temperature gradient capillary electrophoresis (TGCE) (see Li et al., Electrophoresis [electrophoresis] 23 (10): 1499-1511, 2002), or by using enzymatic cleavage fragmentation, such as for use in high throughput methods described by Colbert et al., Plant Physiology [plant physiology] 126: 480-484, 2001. Preferably, the PCR amplification products are incubated with an endonuclease that preferentially cleaves mismatches in heteroduplexes between the wild-type and mutant sequences. According to another aspect of an exemplary embodiment, the cleavage products are electrophoresed using an automated sequencing gel apparatus, and the gel image is analyzed using a standard commercial image processing program.
[0315] The inventors have determined that mutations that alter phospholipase function are desirable in order to achieve haploid induction in corn. Preferred mutations include missense, nonsense, and splice junction changes, including mutations that prematurely truncate phospholipase protein translation from messenger RNA, such as those that generate stop codons within the phospholipase gene coding region. Such mutations include insertions, repeated sequences, modified open reading frames (ORFs), and most preferably point mutations.
[0316] According to another aspect of an exemplary embodiment of the present invention, once an M2 plant with a phospholipase sequence having a mutation is identified, the mutation is analyzed to determine its effect on protein expression, translation and / or activity. According to an exemplary embodiment, the phospholipase fragment containing the mutation is sequenced using standard sequencing techniques to determine the exact position of the mutation relative to the total phospholipase sequence. Each mutation is evaluated to predict its effect on protein function (i.e., fully tolerated to loss of function) using bioinformatics tools such as SIFT (Sorting Intolerant from Tolerant; Ng et al., Nucleic Acids Research 31:3812-3814, 2003), PSSM (Position-Specific Scoring Matrix; Henikoff and Henikoff, Computer Applications in the Biosciences 12:135-143, 1996), and PARSESNP (Taylor and Greene, Nucleic Acids Research 31:3808-3811, 2003). For example, a SIFT score of less than 0.05 and a large change in PSSM score (e.g., about 10 or more) indicate that the mutation may have a deleterious effect on protein function.
[0317] According to another aspect of the exemplary embodiment, if the initial evaluation of the mutation in the M2 plant indicates that it has a useful property and is in a useful position within the phospholipase gene, then proceed to further phenotypic analysis of the corn plant containing the mutation. First, the M2 plant is backcrossed or outcrossed twice to produce a BC1 plant in order to eliminate the background mutation. Then, the backcrossed or outcrossed BC1 plant is self-pollinated to produce a BC1F2 plant that is homozygous for the phospholipase mutation.
[0318] Several physical characteristics of these homozygous phospholipase mutant plants were evaluated to determine whether the mutations resulted in useful phenotypic changes in corn. Haploid induction of mutant phospholipase corn was evaluated compared to normal (e.g., wild-type) parent corn or compared to wild-type sibling control corn. Table 13 shows novel mutations obtained by TILLING.
[0319] Table 13. Novel pPLAIIα mutations and their HIRs obtained by TILLING. The nucleotide change column indicates the position from the beginning of the cDNA sequence (SEQUENCE No. 1), and the changed nucleotides are capitalized in their codon context. The amino acid change is then indicated, followed by the effect of the change (tolerant or intolerant). Of the two intolerant alleles, one induced haploidy at a rate of 1.04% (3 / 288).
[0320]
[0321] The nomenclature used in Table 13 indicates the wild-type nucleotide or amino acid, followed by its position according to reference SEQ ID NO. 1, followed by the altered nucleotide or amino acid at that position using standard genetic code terminology.
[0322] For corn, TILLING corn pPLAIIα gene produces new alleles with low haploid induction rate. This enables the generation of allelic series of GRMZM2G471240, including knockout. The sequences of two segments of this gene (maximum 1.5kb, which is equal to 20 amplicons per gene) are screened for mutations. These sequences include genomic sequences containing introns, plus cDNA sequences and coding sequences of two predicted splice variants. Relevant and unique amplicon sequences are designed based on those sequences, and mutation screening is performed in the existing expanded M2 corn population. The mutants identified are characterized in terms of the consequences of DNA sequence and translated protein sequence. M3 seeds are grown and selfed to produce M4 strains with isolated homozygous individuals of putative mutants. These individuals are identified by PCR sequencing, and outcrossing and selfing are performed to test the ability of these mutant strains to induce haploids.
[0323] In order to perform the test cross, the new strain was grown next to a marker strain that was homozygous recessive for the non-lethal color marker gene. The specificity of induction for male and female transmission was tested using reciprocal crosses by evaluating the resulting haploids of plants that exhibited color phenotypes. Positive hits were confirmed by ploidy analysis as described above.
[0324] Homozygous individuals for SNP mutations were hybridized as males with marker strains females, and in some cases caused low-ratio haploid formation (referring to Table 18). Positive hits were confirmed by ploidy analysis as described above. Specifically, the strains causing haploid formation had a G to A mutation at base pair 1077 of the cDNA sequence. This mutation caused the amino acid replacement of methionine (M) at amino acid 356 to isoleucine (I). This is a non-conservative amino acid change, and the change may destroy the activity of the protein, thereby causing low-ratio haploid formation. In 288 offspring tested, we found 3 haploids, with an induction rate of 1% (3 / 288).
[0325] VI. Generation of Haploid Induced Lines in Rice
[0326] In rice, the closest homolog to maize pPLAIIα is Os03g27610, a rice potato protein-like phospholipase with similar annotation, gene structure, and expression pattern (i.e., expressed in pollen and absent elsewhere). ( Fig.10 ). SEQ ID NO:21 contains the genomic DNA sequence of Os03g27610, SEQ ID NO:22 contains the cDNA sequence, and SEQ ID NO:23 contains the amino acid sequence. The close agreement of these features and the short evolutionary distance between the two grasses suggest that mutations in the rice gene may also generate haploid induced lines. In a recent publication, a rice protein was detected in the sperm nuclei of pollen grains (Abiko et al., 2013), suggesting that this protein is involved in fertilization and / or zygotic development.
[0327] To improve the haploid induction rate in corn and generate the first haploid inducer line in rice, novel mutants were obtained in the corn GRMZM2G471240 gene and the rice Os03g27610 gene using the reverse genetics TILLING method. See McCallum CM et al. (2000) Targeting induced local lesions IN genomes (TILLING) for plant functional genomics [targeting induced local damage in genomes (TILLING) for plant functional genomics], PLANT PHYSIOL. [Plant Physiology] 123: 439–42, incorporated herein by reference). TILLING provides an unbiased method to generate new mutants because researchers cannot control where the ethyl methanesulfonate (EMS) mutagen will generate new mutations. Diverse and abundant new alleles were generated and their haploid induction rates were tested.
[0328] Thirteen different TILLING M3 strains were obtained. See Table 14. The PosGenomic column represents the nucleotide position of the mutation and the change (e.g., G803A represents that the base pair G at position 803 is changed to A). The impact is the amino acid change or other protein change caused by the mutation (e.g., A209T represents that the alanine at amino acid 209 is changed to threonine). The BLOSUM score is a prediction of the intensity of the effect that the amino acid change will have on protein conformation or folding (the greater the negative, the more serious the effect). "Type" represents the type of amino acid change ("NSM" means non-silent mutation; "PSM" means partially silent mutation; "silent" means silent mutation; "splicing" means splice site mutations that cause abnormal splicing; "intron" means mutations in introns). Finally, GSOR# is the strain ID of the Genetic Stocks-Oryza collection of USDA.
[0329] These thirteen lines were selfed to obtain M4, and the M4 seeds were grown and tested for homozygosity. Homozygous mutant individuals were selfed and outcrossed to test haploid induction ability. The DNA content (ploidy) of each cell in the obtained offspring was checked using a ploidy analyzer.
[0330] The non-conservative changes (such as splice site changes and changes with the most negative BLOSUM scores) have the greatest haploid induction potential. These should have more unstable effects on protein products, and are therefore superior haploid induction TILLING alleles compared to other alleles, so that each haploid induction hybridization produces more haploids and may cause partly compromised seeding. In fact, we have begun to see this in some T4 self-pollinations. The strain with the lowest seeding is the splice site mutant G153A, in which the homozygous mutant M4 plants of every 12 hybridizations have only recovered 29 seeds. Other strains have recovered more than 100.
[0331] Table 14. TILLING alleles in rice Os03g27610.
[0332]
[0333] Alternatively, the rice phospholipase gene found in Os03g27610 can be edited by the CRISPR / Cas9 method. As described above, there are three key components in the CRISPR process. The first key component is the target sequence. The second is Cas9, which is an endonuclease. The third key component is the guide RNA ("gRNA"), which is complementary to the target sequence and is responsible for recruiting Cas9 to the desired position. The guide RNA can be in the form of a single guide RNA (sgRNA) or a dual guide RNA (dgRNA). For rice, we generated four constructs targeting the rice phospholipase gene. SEQ ID NO:38 constitutes an expression cassette providing a dgRNA targeting Os03g27610, very close to the position where the natural four-base pair mutation is located in the corn homolog in exon 4. In the rice gene, the guide RNA target site is GAGACCGGCAGGTACGTCGAGG. SEQ ID NO:39 constitutes an expression cassette providing a dgRNA targeting Os03g27610 exon 4, at the same gRNA target site as targeted in SEQ ID NO:38. It is expected that the frameshift mutations of both SEQ ID NOs:38 and 39 will occur where the vertical bar is located between the G and T in the sequence CAGGTACG|TCGAGG (at base pair +1150 of the gDNA sequence of SEQ ID NO:22). Therefore, it is expected that these two constructs will produce haploid inducer mutations that are only 7 base pairs downstream of the location where the maize haploid inducer is inserted. In most cases, these mutations will be frameshift mutations that induce small insertions or deletions, such as a deletion of a G or T at the cleavage site or any other similar mutation. SEQ ID NO:40 constitutes an expression cassette providing a dgRNA targeting Os03g27610. SEQ ID NO:41 constitutes an expression cassette providing an sgRNA targeting Os03g27610. All two have guide RNA, and the sequence CCTCGCCGATTACTTCGACTGCA in described guide RNA targeting exon 1.This should produce the knockout of most coding sequences of described gene.The mutation produced should occur at the cleavage site, and here the vertical bar is between C and C in sequence CCTCGC|CGATTAC (base pair +215 of cDNA sequence in SEQ ID NO:22).Therefore, it is expected that construct 40 and 41 will produce high frequency plant containing gene knockout mutation, which should also result in high haploid induction rate in rice.
[0334] Rice plants are transformed with transformation constructs comprising sequences selected from the group consisting of SEQ ID NO:38–41. New phospholipase alleles are produced in transformants (i.e., T0 rice plants) by CRISPR / Cas9 machines encoded in the transformation constructs. T0 rice plants are grown and hybridized (i.e., self-pollination) to produce T1 plants. Homozygosity of T1 rice plants is tested at new phospholipase alleles. Homozygous T1 rice plants are hybridized with rice lines, and the haploidy of the resulting offspring is tested using a ploidy analyzer. Haploid embryos without detectable T1 DNA are identified and counted, and HIR is measured. At least one haploid embryo is produced from hybridization, and HIR increases. Preferably, HIR is at least 5%. At least one haploid embryo is treated with a chromosome doubling agent (e.g., colchicine), and double haploid plants are grown therefrom.
[0335] Some embodiments of the present invention are as follows:
[0336] 1. A method for inducing haploid seed production, the method comprising treating the reproductive tissue of a plant with a composition comprising a compound according to formula (I): in
[0337] (a) W is C, P or S;
[0338] (b) m and n are each independently 0 or 1;
[0339] (c) X is selected from the group consisting of OH, CN, O(C 1 -C 4 alkyl), halogen, C 1 -C 4 Alkyl, and C substituted by one, two or three halogen or carbonyl groups 1 -C 4 alkyl;
[0340] (d) R 1 yes:
[0341] (i) is selected from the group consisting of: H, C 1 -C 6 Alkyl and C substituted with one or more hydroxyl groups 1 -C 6 Alkyl, wherein optionally one or more of the hydroxyl groups are esterified by a group independently selected from the group consisting of:
[0342] or
[0343] (ii) when W is S, the bond to W;
[0344] (e) Each L is independently C2 -C 30 A carbon chain optionally comprising one or more groups independently selected from alkenyl, alkynyl, phenyl and heteroaryl, and optionally interrupted by 1-6 oxygen atoms.
[0345] (f) provided that when W is C and m is 1, n is 0; and
[0346] (g) provided that when W is C and m is 0, n is 1;
[0347] wherein the treating occurs immediately before, during or immediately after pollination and wherein at least one haploid seed is produced.
[0348] 2. A method for inducing haploid seed production, the method comprising treating the reproductive tissue of a plant with a composition comprising a compound according to formula (I): in
[0349] (a) W is C or P;
[0350] (b) m and n are each independently 0 or 1;
[0351] (c) X is selected from the group consisting of OH, CN, O(C 1 –C 4 alkyl), halogen, C 1 –C 4 Alkyl, and C substituted by one, two or three halogen or carbonyl groups 1 –C 4 alkyl;
[0352] (d) R 1 Selected from the group consisting of: H, C 1 –C 4 Alkyl and C substituted with one or more hydroxyl groups 1 –C 4 alkyl;
[0353] (e) L is C 2 –C 30 A carbon chain, the carbon chain optionally comprising one or more groups independently selected from the group consisting of alkenyl and alkynyl, and the carbon chain optionally being interrupted by 1-6 oxygen atoms;
[0354] (f) provided that when W is C and m is 1, n is 0; and
[0355] (g) provided that when W is C and m is 0, n is 1;
[0356] wherein the treating occurs immediately before, during or immediately after pollination and wherein at least one haploid seed is produced.
[0357] 3. The method according to embodiments 1-2, wherein L of formula (I) is selected from the group consisting of:
[0358] (a)(CH 2 ) 8 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -CH 3 ;
[0359] (b)(CH 2 ) 3 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -CH 2 -(CH) 2 -(CH 2 ) 4 -CH 3 ;
[0360] (c)(CH 2 ) 7 -(CH) 2 -(CH 2 ) 7 -CH 3 ;
[0361] (d)(CH 2 ) 8 -(CH) 2 -CH 2 -phenyl-CH 2 -(CH) 2 -CH 2 -CH 3 ;
[0362] (e)(CH 2 ) 8 -(CH) 2 -(CH 2 ) 2 -O-CH 2 -(CH) 2 -CH 2 -CH 3 ;as well as
[0363] (f)(CH 2 ) 8 -(CH) 2 -CH 2 -phenyl-O-(CH 2 ) 3 -CH 3 .
[0364] 4. A method for inducing haploid seed production in a cross between two plants, the method comprising treating reproductive tissue of at least one plant with a composition comprising a lipid or a phospholipase inhibitor, wherein the treatment occurs immediately before, during or after pollination, and wherein at least one haploid seed is produced from the cross.
[0365] 5. A method for inducing haploid seed production, the method comprising treating reproductive tissue of a plant with a composition comprising a lipid or a phospholipase inhibitor, wherein the treatment occurs immediately before, during or after pollination, and wherein at least one haploid seed is produced.
[0366] 6. The method of embodiment 4 or 5, wherein the haploid seeds are induced at an increased rate.
[0367] 7. The method of embodiment 4 or 5, wherein the lipid or the phospholipase inhibitor is selected from the group consisting of the compounds listed in Table 7.
[0368] 8. A method as described in embodiment 7, wherein the lipid or the phospholipase inhibitor is selected from the group consisting of: methyl α-linolenoyl fluorophosphonate ("MALFP"), linoleic acid ethyl ester ("LLAEE"), linoleic acid ("LLA"), corn oil, distearoyl-phosphatidylcholine ("DSPC"), or methyl arachidonyl fluorophosphonate ("MAFP").
[0369] 9. The method of embodiment 4 or 5, wherein the composition of lipid or phospholipase inhibitor comprises a compound selected from Table 7, dissolved or emulsified in a suitable formulation at a concentration between 0.0001 mg / mL and 100 mg / mL, or between 0.1 mg / mL and 50 mg / mL, or between 1 mg / mL and 10 mg / mL, or about 5 mg / mL.
[0370] 10. The method of embodiment 9, wherein the suitable formulation is selected from the group consisting of water, alcohol, DMSO, Tris-EDTA, EDTA, acetic acid, benzene, DME, glycerol, hexane, ethanol, isopropanol, propanol, buffered saline, glycine-HCl, sodium acetate, cacodylate buffer, citrate buffer, Phosphate buffer and phosphate-citrate buffer, barbiturate buffer, Tris buffer, glycine-NaOH buffer, Formulation 91, Formulation 92, phosphate buffered saline ("PBS"), PBS plus Tween and DMSO, and any other useful solvent or buffer in which the fatty acid can be diluted or emulsified.
[0371] 11. The method of embodiment 10, wherein the suitable compound is phosphate buffered saline ("PBS").
[0372] 12. The method of embodiment 4 or 5, wherein the plant is a dicotyledonous plant.
[0373] 13. The method of embodiment 4 or 5, wherein the plant is a monocot.
[0374] 14. The method of embodiment 13, wherein the plant is rice.
[0375] 15. The method of embodiment 13, wherein the plant is corn.
[0376] 16. The method of embodiment 12, wherein the dicot is sunflower or soybean.
[0377] 17. The method of embodiment 4 or 5, wherein the lipid is applied by a technique selected from the group consisting of dipping, injection, spray-based topical application, nebulizer, pipette-based topical application, and brush-based topical application, and any other topical application.
[0378] 18. A method for inducing haploid embryos in a cross between two plants, the method comprising:
[0379] (a) expressing a mutant potato glycoprotein-like phospholipase in a plant; or
[0380] (b) applying to the plant a small interfering RNA molecule of 18-21 nucleotides comprising a gene encoding a potato glycoprotein-like phospholipase; or
[0381] (c) transforming a plant with a mutant potato glycoprotein-like phospholipase; or
[0382] (d) using gene editing to mutate the potato protein-like phospholipase sequence of plants;
[0383] wherein the plant is used as a parent plant in a cross between two plants such that the cross produces at least one haploid embryo.
[0384] 19. The method of embodiment 18, wherein the potato glycoprotein-like phospholipase is encoded by a nucleic acid sequence comprising SEQ ID NO: 1 or a sequence having 70% identity to SEQ ID NO: 1.
[0385] 20. The method of embodiment 18, wherein the mutant potato glycoprotein-like phospholipase is encoded by a nucleic acid comprising SEQ ID NO: 3 or a sequence having 70% identity to SEQ ID NO: 3.
[0386] 21. A method as described in embodiment 18, wherein the gene editing in step (d) is achieved by site-directed mutagenesis.
[0387] 22. The method of embodiment 21, wherein the site-directed mutagenesis is achieved by a technique selected from the group consisting of CRISPR / Cas9, TALEN, zinc fingers, and meganucleases.
[0388] 23. The method of embodiment 18, wherein the cross between two plants is between two monocotyledonous plants, or between two dicotyledonous plants, or between a monocotyledonous plant and a dicotyledonous plant.
[0389] 24. The method of embodiment 23, wherein the two monocotyledonous plants are corn plants, rice plants, wheat plants, or barley plants.
[0390] 25. The method of embodiment 23, wherein the two dicotyledonous plants are soybean plants, sunflower plants, tomato plants, pepper plants, bean plants, sugar beet plants, or Brussels sprouts plants.
[0391] 26. The method of embodiment 18, wherein the plant used as a parent plant in the cross is a corn plant or a rice plant.
[0392] 27. The method of embodiment 26, wherein the corn plant or the rice plant provides pollen used in the crossing.
[0393] 28. The method of embodiment 18, wherein the small interfering RNA molecule comprises 18-21 consecutive nucleotides of SEQ ID NO: 1.
[0394] 29. A haploid embryo produced by the method of embodiment 18.
[0395] 30. A haploid plant produced from the haploid embryo of embodiment 29.
[0396] 31. A haploid seed comprising the haploid embryo of embodiment 29.
[0397] 32. A doubled haploid plant produced from the haploid embryo of embodiment 29, wherein the haploid embryo is exposed to a chromosome doubling agent.
[0398] 33. The doubled haploid plant of embodiment 32, wherein the chromosome doubling agent is selected from the group consisting of colchicine and trifluralin.
[0399] 34. A cDNA comprising SEQ ID NO:3, a sequence orthologous to SEQ ID NO:3, or a sequence having 70% identity to SEQ ID NO:3.
[0400] 35. The cDNA of embodiment 34, wherein the sequence orthologous to SEQ ID NO: 3 comprises a sequence selected from the group consisting of SEQ ID NO: 22 and a nucleotide sequence encoding any one of SEQ ID NOs: 73–81.
[0401] 36. A plant comprising a non-transgenic human-induced mutation in a potato glycoprotein-like phospholipase gene.
[0402] 37. The plant of embodiment 36, wherein the human-induced non-transgenic mutation is an insertion of at least one nucleotide, a deletion of at least one nucleotide, or a substitution of at least one nucleotide, and wherein the mutation generates a premature stop codon in the potato glycoprotein-like phospholipase gene.
[0403] 38. A seed, a pollen grain, a plant part, or progeny of the plant of embodiment 36; wherein the seed, the pollen grain, the plant part, or the progeny comprises the mutation.
[0404] 39. The plant of any one of embodiments 37-38, wherein the plant is selected from the group consisting of maize (Zea mays), sorghum (Sorghum bicolor), millet (Setaria italica), barley (Hordeum vulgare), stiff brome (Brachypodium distachyon), rice (Oryza sativa), wheat (Triticum aestivum), banana (Musa acuminata), palm (Elaeis guineensis), oats (Avena sativa), sunflower (Helianthus annuus), sugar beet (Beta vulgaris), Arabidopsis thaliana, and soybean (Glycine max).
[0405] 40. The plant of embodiment 39, wherein the plant is a corn plant.
[0406] 41. The plant of embodiment 39, wherein the plant is a rice plant.
[0407] 42. The plant of embodiment 37, wherein the patatin-like phosphatase gene comprises SEQ ID NO: 1, a sequence orthologous to SEQ ID NO: 1, or a sequence with 70% identity to SEQ ID NO: 1.
[0408] 43. The plant of embodiment 42, wherein the potato glycoprotein-like phospholipase gene comprises SEQ ID NO: 3.
Claims
1. A cDNA consisting of SEQ ID NO: 3.
Citation Information
Patent Citations
Chimeric gene comprising the arabidopsis histone H4 promoter for the transformation of plants
US5491288A
CRISPR-Cas systems and methods for altering expression of gene products
US8697359B1
Molecular markers associated with haploid induction in ZEA mays
WO2012030893A1
Method for inducing corn haploids
CN104335889A
Maize microrna sequences and targets thereof for agronomic traits
WO2014151749A1
